LESAKA TECHNOLOGIES INC 10-Q

Item 1. Financial Statements LESAKA TECHNOLOGIES, INC. Unaudited Condensed Consolidated Balance Sheets March 31, June 30, 2024 2023 (A) (In thousands, except share data) ASSETS CURRENT ASSETS Cash and cash equivalents $ 55,223 $ 35,499 Restricted cash related to ATM funding and credit facilities (Note 8) 4,383 23,133 Accounts receivable, net and other receivables (Note 2) 34,331 25,665 Finance loans receivable, net (Note 2) 40,754 36,744 Inventory (Note 3) 21,789 27,337 Total current assets before settlement assets 156,480 148,378 Settlement assets 29,300 15,258 Total current assets 185,780 163,636 PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation of - March: $ 40,276 June: $ 36,563 27,918 27,447 OPERATING LEASE RIGHT-OF-USE (Note 16) 5,533 4,731 EQUITY-ACCOUNTED INVESTMENTS (Note 5) 159 3,171 GOODWILL (Note 6) 133,473 133,743 INTANGIBLE ASSETS, NET (Note 6) 110,798 121,597 DEFERRED INCOME TAXES 9,793 10,315 OTHER LONG-TERM ASSETS, including reinsurance assets (Note 5 and 7) 78,035 77,594 TOTAL ASSETS 551,489 542,234 LIABILITIES CURRENT LIABILITIES Short-term credit facilities for ATM funding (Note 8) 4,272 23,021 Short-term credit facilities (Note 8) 9,006 9,025 Accounts payable 19,018 12,380 Other payables (Note 9) 49,470 36,297 Operating lease liability - current (Note 16) 1,763 1,747 Current portion of long-term borrowings (Note 8) 3,269 3,663 Income taxes payable 1,565 1,005 Total current liabilities before settlement obligations 88,363 87,138 Settlement obligations 27,820 14,774 Total current liabilities 116,183 101,912 DEFERRED INCOME TAXES 43,878 46,840 OPERATING LEASE LIABILITY - LONG TERM (Note 16) 3,912 3,138 LONG-TERM BORROWINGS (Note 8) 132,398 129,455 OTHER LONG-TERM LIABILITIES, including insurance policy liabilities (Note 7) 2,602 1,982 TOTAL LIABILITIES 298,973 283,327 REDEEMABLE COMMON STOCK 79,429 79,429 EQUITY COMMON STOCK (Note 10) Authorized: 200,000,000 with $ 0.001 par value; Issued and outstanding shares, net of treasury - March: 64,466,830 June: 63,640,246 83 83 PREFERRED STOCK Authorized shares: 50,000,000 with $ 0.001 par value; Issued and outstanding shares, net of treasury: March: - June: - - - ADDITIONAL PAID-IN-CAPITAL 341,287 335,696 TREASURY SHARES, AT COST: March: 25,297,772 June: 25,244,286 ( 288,445 ) ( 288,238 ) ACCUMULATED OTHER COMPREHENSIVE LOSS (Note 11) ( 195,096 ) ( 195,726 ) RETAINED EARNINGS 315,258 327,663 TOTAL LESAKA EQUITY 173,087 179,478 NON-CONTROLLING INTEREST - - TOTAL EQUITY 173,087 179,478 TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND SHAREHOLDERS’ EQUITY $ 551,489 $ 542,234 (A) – Derived from audited financial statements See Notes to Unaudited Condensed Consolidated Financial Statements LESAKA TECHNOLOGIES, INC. Unaudited Condensed Consolidated Statements of Operations 3 Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 (In thousands, except per share data) (In thousands, except per share data) REVENUE (Note 15) $ 138,194 $ 133,968 $ 418,176 $ 394,822 EXPENSE Cost of goods sold, IT processing, servicing and support 107,854 105,299 329,610 314,651 Selling, general and administration 23,124 24,547 67,146 70,995 Depreciation and amortization 5,791 5,975 17,460 17,892 Transaction costs related to Adumo acquisition (Note 20) 631 - 665 - OPERATING INCOME (LOSS) 794 ( 1,853 ) 3,295 ( 8,716 ) REVERSAL OF ALLOWANCE FOR DOUBTFUL EMI DEBT RECEIVABLE - - 250 - (LOSS) GAIN ON DISPOSAL OF EQUITY-ACCOUNTED INVESTMENT (Note 5) - ( 329 ) - ( 193 ) INTEREST INCOME 628 469 1,562 1,269 INTEREST EXPENSE 4,581 4,984 14,312 13,408 LOSS BEFORE INCOME TAX EXPENSE (BENEFIT) ( 3,159 ) ( 6,697 ) ( 9,205 ) ( 21,048 ) INCOME TAX EXPENSE (BENEFIT) (Note 18) 931 ( 860 ) 1,881 ( 465 ) NET LOSS BEFORE EARNINGS (LOSS) FROM EQUITY- ACCOUNTED INVESTMENTS ( 4,090 ) ( 5,837 ) ( 11,086 ) ( 20,583 ) EARNINGS (LOSS) FROM EQUITY-ACCOUNTED INVESTMENTS (Note 5) 43 17 ( 1,319 ) ( 2,582 ) NET LOSS ATTRIBUTABLE TO LESAKA $ ( 4,047 ) $ ( 5,820 ) $ ( 12,405 ) $ ( 23,165 ) Net loss per share, in United States dollars (Note 13): Basic loss attributable to Lesaka shareholders $ ( 0.06 ) $ ( 0.09 ) $ ( 0.20 ) $ ( 0.37 ) Diluted loss attributable to Lesaka shareholders $ ( 0.06 ) $ ( 0.09 ) $ ( 0.20 ) $ ( 0.37 ) See Notes to Unaudited Condensed Consolidated Financial Statements LESAKA TECHNOLOGIES, INC. Unaudited Condensed Consolidated Statements of Comprehensive (Loss) Income 4 Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 (In thousands) (In thousands) Net loss $ ( 4,047 ) $ ( 5,820 ) $ ( 12,405 ) $ ( 23,165 ) Other comprehensive (loss) income, net of taxes Movement in foreign currency translation reserve ( 5,718 ) ( 9,775 ) ( 450 ) ( 19,713 ) Release of foreign currency translation reserve related to disposal of Finbond equity securities (Note 11) - 243 1,543 342 Release of foreign currency translation reserve related to liquidation of subsidiaries - - ( 952 ) - Movement in foreign currency translation reserve related to equity-accounted investments - 216 489 2,657 Total other comprehensive income (loss), net of taxes ( 5,718 ) ( 9,316 ) 630 ( 16,714 ) Comprehensive loss ( 9,765 ) ( 15,136 ) ( 11,775 ) ( 39,879 ) Comprehensive loss attributable to Lesaka $ ( 9,765 ) $ ( 15,136 ) $ ( 11,775 ) $ ( 39,879 ) See Notes to Unaudited Condensed Consolidated Financial Statements LESAKA TECHNOLOGIES, INC. Unaudited Condensed Consolidated Statements of Changes in Equity 5 Lesaka Technologies, Inc. Shareholders Number of Shares Amount Number of Treasury Shares Treasury Shares Number of shares, net of treasury Additional Paid-In Capital Retained Earnings Accumulated other comprehensive loss Total Lesaka Equity Non- controlling Interest Total Redeemable common stock For the three months ended March 31, 2023 (dollar amounts in thousands) Balance – January 1, 2023 88,708,191 $ 83 ( 24,956,854 ) $ ( 287,244 ) 63,751,337 $ 332,537 $ 345,392 $ ( 176,238 ) $ 214,530 $ - $ 214,530 $ 79,429 Shares repurchased (Note 12) ( 37,945 ) ( 178 ) ( 37,945 ) - ( 178 ) ( 178 ) Restricted stock granted (Note 12) 11,806 11,806 - - Exercise of stock options 37,500 - 37,500 114 114 114 Stock-based compensation charge (Note 12) - 1,667 1,667 1,667 Reversal of stock-based compensation charge (Note 12) ( 18,798 ) ( 18,798 ) ( 23 ) ( 23 ) ( 23 ) Stock-based compensation charge related to equity-accounted investment (Note 5) - ( 9 ) ( 9 ) ( 9 ) Net loss - ( 5,820 ) ( 5,820 ) - ( 5,820 ) Other comprehensive income (Note 11) ( 9,316 ) ( 9,316 ) - ( 9,316 ) Balance – March 31, 2023 88,738,699 $ 83 ( 24,994,799 ) $ ( 287,422 ) 63,743,900 $ 334,286 $ 339,572 $ ( 185,554 ) $ 200,965 $ - $ 200,965 $ 79,429 For the nine months ended March 31, 2023 (dollar amounts in thousands) Balance – July 1, 2022 87,215,613 $ 83 ( 24,891,292 ) $ ( 286,951 ) 62,324,321 $ 327,891 $ 362,737 $ ( 168,840 ) $ 234,920 $ - $ 234,920 $ 79,429 Share repurchased (Note 12) - ( 103,507 ) ( 471 ) ( 103,507 ) ( 471 ) ( 471 ) Restricted stock granted 1,394,558 1,394,558 - - Exercise of stock options 147,326 - 147,326 447 447 447 Stock-based compensation charge (Note 12) 5,978 5,978 5,978 Reversal of stock-based compensation charge (Note 12) ( 18,798 ) ( 18,798 ) ( 23 ) ( 23 ) ( 23 ) Stock-based compensation charge related to equity-accounted investment ( 7 ) ( 7 ) ( 7 ) Net loss ( 23,165 ) ( 23,165 ) - ( 23,165 ) Other comprehensive loss (Note 11) ( 16,714 ) ( 16,714 ) - ( 16,714 ) Balance – March 31, 2023 88,738,699 $ 83 ( 24,994,799 ) $ ( 287,422 ) 63,743,900 $ 334,286 $ 339,572 $ ( 185,554 ) $ 200,965 $ - $ 200,965 $ 79,429 See Notes to Unaudited Condensed Consolidated Financial Statements LESAKA TECHNOLOGIES, INC. Unaudited Condensed Consolidated Statements of Changes in Equity 6 Lesaka Technologies, Inc. Shareholders Number of Shares Amount Number of Treasury Shares Treasury Shares Number of shares, net of treasury Additional Paid-In Capital Retained Earnings Accumulated other comprehensive loss Total Lesaka Equity Non- controlling Interest Total Redeemable common stock For the three months ended March 31, 2024 (dollar amounts in thousands) Balance – January 1, 2024 89,738,784 $ 83 ( 25,295,261 ) $ ( 288,436 ) 64,443,523 $ 339,149 $ 319,305 $ ( 189,378 ) $ 180,723 $ - $ 180,723 $ 79,429 Shares repurchased (Note 12) - ( 2,511 ) ( 9 ) ( 2,511 ) ( 9 ) ( 9 ) Restricted stock granted (Note 12) 65,525 65,525 - - Exercise of stock option (Note 12) 15,832 - 15,832 48 48 48 Stock-based compensation charge (Note 12) - - 2,202 2,202 2,202 Reversal of stock-based compensation charge (Note 12) ( 55,539 ) ( 55,539 ) ( 112 ) ( 112 ) ( 112 ) Stock-based compensation charge related to equity-accounted investment (Note 5) - - - Net loss ( 4,047 ) ( 4,047 ) - ( 4,047 ) Other comprehensive loss (Note 11) ( 5,718 ) ( 5,718 ) - ( 5,718 ) Balance – March 31, 2024 89,764,602 $ 83 ( 25,297,772 ) $ ( 288,445 ) 64,466,830 $ 341,287 $ 315,258 $ ( 195,096 ) $ 173,087 $ - $ 173,087 $ 79,429 For the nine months ended March 31, 2024 (dollar amounts in thousands) Balance – July 1, 2023 88,884,532 $ 83 ( 25,244,286 ) $ ( 288,238 ) 63,640,246 $ 335,696 $ 327,663 $ ( 195,726 ) $ 179,478 $ - $ 179,478 $ 79,429 Shares repurchased (Note 12) ( 53,486 ) ( 207 ) ( 53,486 ) ( 207 ) ( 207 ) Restricted stock granted 934,521 934,521 - - - Exercise of stock option (Note 12) 23,217 - 23,217 71 71 71 Stock-based compensation charge (Note 12) - - 5,782 5,782 5,782 Reversal of stock-based compensation charge (Note 12) ( 77,668 ) ( 77,668 ) ( 129 ) ( 129 ) ( 129 ) Stock-based compensation charge related to equity-accounted investment (Note 5) ( 133 ) ( 133 ) ( 133 ) Net loss ( 12,405 ) ( 12,405 ) - ( 12,405 ) Other comprehensive income (Note 11) 630 630 - 630 Balance – March 31, 2024 89,764,602 $ 83 ( 25,297,772 ) $ ( 288,445 ) 64,466,830 $ 341,287 $ 315,258 $ ( 195,096 ) $ 173,087 $ - $ 173,087 $ 79,429 See Notes to Unaudited Condensed Consolidated Financial Statements LESAKA TECHNOLOGIES, INC. Unaudited Condensed Consolidated Statements of Cash Flows 7 Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 (In thousands) (In thousands) Cash flows from operating activities Net loss $ ( 4,047 ) $ ( 5,820 ) $ ( 12,405 ) $ ( 23,165 ) Depreciation and amortization 5,791 5,975 17,460 17,892 Movement in allowance for doubtful accounts receivable 843 1,638 3,532 4,167 Fair value adjustment related to financial liabilities ( 49 ) ( 21 ) ( 919 ) 123 Loss on disposal of equity-accounted investments (Note 5) - 329 - 193 (Earnings) Loss from equity-accounted investments ( 43 ) ( 17 ) 1,319 2,582 Movement in allowance for doubtful loans to equity-accounted investments - - ( 250 ) - Profit on disposal of property, plant and equipment ( 89 ) ( 145 ) ( 288 ) ( 466 ) Movement in interest payable 1,054 1,827 1,245 3,289 Facility fee amortized 65 198 381 643 Stock-based compensation charge (Note 12) 2,090 1,644 5,653 5,955 Dividends received from equity-accounted investments 41 - 95 21 Decrease (Increase) in accounts receivable 5,687 ( 7,620 ) ( 9,815 ) ( 8,601 ) Increase in finance loans receivable ( 3,720 ) ( 2,507 ) ( 7,097 ) ( 11,318 ) Decrease (Increase) in inventory 5,000 ( 297 ) 5,506 ( 1,769 ) Increase in accounts payable and other payables 6,463 1,030 20,566 5,421 Increase in taxes payable 904 1,349 558 1,478 Decrease in deferred taxes ( 810 ) ( 2,670 ) ( 2,404 ) ( 5,792 ) Net cash provided by (used in) operating activities 19,180 ( 5,107 ) 23,137 ( 9,347 ) Cash flows from investing activities Capital expenditures ( 2,943 ) ( 4,717 ) ( 7,950 ) ( 13,210 ) Proceeds from disposal of property, plant and equipment 395 394 1,115 1,156 Acquisition of intangible assets ( 54 ) ( 125 ) ( 236 ) ( 245 ) Proceeds from disposal of equity-accounted investment (Note 5) - 254 3,508 645 Loan to equity-accounted investment (Note 5) - - - ( 112 ) Repayment of loans by equity-accounted investments - - 250 112 Net change in settlement assets ( 3,088 ) 11,043 ( 14,368 ) ( 972 ) Net cash (used in) provided by investing activities ( 5,690 ) 6,849 ( 17,681 ) ( 12,626 ) Cash flows from financing activities Proceeds from bank overdraft (Note 8) 24,893 128,196 153,479 441,488 Repayment of bank overdraft (Note 8) ( 43,380 ) ( 135,986 ) ( 172,221 ) ( 448,288 ) Long-term borrowings utilized (Note 8) 3,398 12,868 14,426 23,010 Repayment of long-term borrowings (Note 8) ( 7,238 ) ( 2,024 ) ( 13,051 ) ( 5,292 ) Acquisition of treasury stock (Note 12) ( 9 ) ( 178 ) ( 207 ) ( 471 ) Proceeds from exercise of stock options 48 114 71 447 Guarantee fee - - - ( 100 ) Net change in settlement obligations 2,469 ( 10,761 ) 13,362 807 Net cash (used in) provided by financing activities ( 19,819 ) ( 7,771 ) ( 4,141 ) 11,601 Effect of exchange rate changes on cash and cash equivalents ( 1,903 ) ( 3,475 ) ( 341 ) ( 7,156 ) Net (decrease) increase in cash, cash equivalents and restricted cash ( 8,232 ) ( 9,504 ) 974 ( 17,528 ) Cash, cash equivalents and restricted cash – beginning of period 67,838 96,776 58,632 104,800 Cash, cash equivalents and restricted cash – end of period (Note 14) $ 59,606 $ 87,272 $ 59,606 $ 87,272 See Notes to Unaudited Condensed Consolidated Financial Statements 8 LESAKA TECHNOLOGIES, INC Notes to the Unaudited Condensed Consolidated Financial Statements for the three and nine months ended March 31, 2024 and 2023 (All amounts in tables stated in thousands or thousands of U.S. dollars, unless otherwise stated) 1. Basis of Presentation and Summary of Significant Accounting Policies Unaudited Interim Financial Information The accompanying unaudited condensed consolidated financial statements include all majority-owned subsidiaries over which the Company exercises control and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the United States Securities and Exchange Commission for Quarterly Reports on Form 10-Q and include all of the information and disclosures required for interim financial reporting. The results of operations for the three and nine months ended March 31, 2024 and 2023, are not necessarily indicative of the results for the full year. The Company believes that the disclosures are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements, accounting policies and financial notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments), which are necessary for a fair representation of financial results for the interim periods presented. References to “Lesaka” are references solely to Lesaka Technologies, Inc. References to the “Company” refer to Lesaka and its consolidated subsidiaries, collectively, unless the context otherwise requires. Recent accounting pronouncements adopted In June 2016, the Financial Accounting Standards Board (“FASB”) issued guidance regarding Measurement of Credit Losses on Financial Instruments . The guidance replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans, and other financial instruments, an entity is required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The guidance became effective for the Company beginning July 1, 2023. The adoption of this guidance did not have a material impact on the Company’s financial statements and related disclosures, refer to Note 2. In November 2019, the FASB issued guidance regarding Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). The guidance provides a framework to stagger effective dates for future major accounting standards and amends the effective dates for certain major new accounting standards to give implementation relief to certain types of entities, including Smaller Reporting Companies. The Company is a Smaller Reporting Company. Specifically, the guidance changes some effective dates for certain new standards on the following topics in the FASB Codification, namely Derivatives and Hedging (ASC 815); Leases (ASC 842); Financial Instruments — Credit Losses (ASC 326); and Intangibles — Goodwill and Other (ASC 350). The guidance defers the adoption date of guidance regarding Measurement of Credit Losses on Financial Instruments by the Company from July 1, 2020 to July 1, 2023. The guidance became effective for the Company beginning July 1, 2023. The adoption of this guidance did not have a material impact on the Company’s financial statements and related disclosures, refer to Note 2. The Company’s updated accounting policy regarding allowance for credit losses is as follows: Allowance for doubtful accounts receivable Allowance for doubtful finance loans receivable The Company uses historical default experience over the lifetime of loans in order to calculate a lifetime loss rate for its lending books. The allowance for credit losses related to Consumer finance loans receivables is calculated by multiplying the lifetime loss rate with the month-end outstanding lending book. The allowance for credit losses related to Merchant finance loans receivables is calculated by adding together actual receivables in default plus multiplying the lifetime loss rate with the month-end outstanding lending book. Prior to July 1, 2023, the Company regularly reviewed the ageing of outstanding amounts due from borrowers and adjusted its allowance based on management’s estimate of the recoverability of the finance loans receivable. The Company writes off microlending finance loans receivable and related service fees and interest if a borrower is in arrears with repayments for more than three months or is deceased. The Company writes off merchant and working capital finance receivables and related fees when it is evident that reasonable recovery procedures, including where deemed necessary, formal legal action, have failed. 9 1. Basis of Presentation and Summary of Significant Accounting Policies (continued) Allowance for doubtful accounts receivable (continued) Allowance for doubtful accounts receivable The Company uses a lifetime loss rate by expressing write-off experience as a percentage of corresponding invoice amounts (as opposed to outstanding balances). The allowance for credit losses related to these receivables has been calculated by multiplying the lifetime loss rate with recent invoice/origination amounts. Prior to July 1, 2023, a specific provision is established where it is considered likely that all or a portion of the amount due from customers renting safe assets, point of sale (“POS”) equipment, receiving support and maintenance or transaction services or purchasing licenses or SIM cards from the Company will not be recovered. Non- recoverability is assessed based on a quarterly review by management of the ageing of outstanding amounts, the location and the payment history of the customer in relation to those specific amounts. Recent accounting pronouncements not yet adopted as of March 31, 2024 In November 2023. the FASB issued guidance regarding Segment Reporting (Topic 280) to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the guidance enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment, and contains other disclosure requirements. This guidance is effective for the Company beginning July 1, 2024 for its year ended June 30, 2025, and for interim periods commencing from July 1, 2025 (i.e. for the quarter ended September 30, 2025). The Company is currently assessing the impact of this guidance on its financial statements and related disclosures. In December 2023, the FASB issued guidance regarding Income Taxes (Topic 740) to improve income tax disclosure requirements. The guidance requires entities, on an annual basis, to (1) disclose specific categories in the income tax rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than five percent of the amount computed by multiplying pre-tax income or loss by the applicable statutory income tax rate). This guidance is effective for the Company beginning July 1, 2025. The Company is currently assessing the impact of this guidance on its financial statements and related disclosures. 2. Accounts receivable, net and other receivables and finance loans receivable, net Accounts receivable, net and other receivables The Company’s accounts receivable, net, and other receivables as of March 31, 2024, and June 30, 2023, are presented in the table below: March 31, June 30, 2024 2023 Accounts receivable, trade, net $ 12,970 $ 11,037 Accounts receivable, trade, gross 13,055 11,546 Allowance for doubtful accounts receivable, end of period 85 509 Beginning of period 509 509 Reallocation to allowance for doubtful finance loans receivable - ( 418 ) Reversed to statement of operations ( 435 ) ( 31 ) Charged to statement of operations 828 2,005 Utilized ( 819 ) ( 1,645 ) Foreign currency adjustment 2 89 Current portion of amount outstanding related to sale of interest in Carbon, net of allowance: March 2024: $ 750 ; June 2023: $ 750 - - Current portion of total held to maturity investments - - Investment in 7.625 % of Cedar Cellular Investment 1 (RF) (Pty) Ltd 8.625 % notes - - Other receivables 21,361 14,628 Total accounts receivable, net and other receivables $ 34,331 $ 25,665 Trade receivables include amounts due from customers which generally have a very short-term life from date of invoice or service provided to settlement. The duration is less than a year in all cases and generally less than 30 days in many instances. The short-term nature of these exposures often results in balances at month-end that are disproportionately small compared to the total invoiced amounts. The month-end outstanding balance are more volatile than the monthly invoice amounts because they are affected by operational timing issues and the fact that a balance is outstanding at month-end is not necessarily an indication of increased risk but rather a matter of operational timing. 10 2. Accounts receivable, net and other receivables and finance loans receivable, net (continued) Accounts receivable, net and other receivables (continued) Credit risk in respect of trade receivables are generally not significant and the Company has not developed a sophisticated model for these basic credit exposures. The Company determined to use a lifetime loss rate by expressing write-off experience as a percentage of corresponding invoice amounts (as opposed to outstanding balances). The allowance for credit losses related to these receivables has been calculated by multiplying the lifetime loss rate with recent invoice/origination amounts. Management actively monitors performance of these receivables over short periods of time. Different balances have different rules to identify an account in distress but, generally speaking, account balances in distress are identified very early and specific allowances are immediately created. Subsequent recovery from distressed accounts is generally limited. Current portion of amount outstanding related to sale of interest in Carbon represents the amount due from the purchaser related to the sale of the Company’s interest in Carbon Tech Limited (“Carbon”), an equity-accounted investment of $ 0.25 million, net of an allowance for doubtful loans receivable of $ 0.25 million as of June 30, 2023, and an amount due related to the sale of the loan, with a face value of $ 3.0 million, which was sold in September 2022 for $ 0.75 million, net of an allowance for doubtful loans receivable of $ 0.75 million, refer to Note 5 for additional information. The Company received the outstanding $ 0.25 million related to the sale of the equity-accounted investment in October 2023, and has reversed the allowance for doubtful loans receivable of $ 0.25 million during the nine months ended December 31, 2023. The Company has not yet received the outstanding $ 0.75 million related to the sale of the $ 3.0 million loan, and continues to engage with the purchaser to recover the outstanding balance. Investment in 7.625 % of Cedar Cellular Investment 1 (RF) (Pty) Ltd 8.625 % notes represents the investment in a note which was due to mature in August 2022 and forms part of Cell C’s capital structure. The carrying value as of each of March 31, 2024, and June 30, 2023, respectively was $ 0 (zero). Other receivables include prepayments, deposits, income taxes receivable and other receivables. Contractual maturities of held to maturity investments Summarized below is the contractual maturity of the Company’s held to maturity investment as of March 31, 2024: Cost basis Estimated fair value (1) Due in one year or less $ - $ - Due in one year through five years (2) - - Due in five years through ten years - - Due after ten years - - Total $ - $ - (1) The estimated fair value of the Cedar Cellular note has been calculated utilizing the Company’s portion of the assets held by Cedar Cellular, namely, Cedar Cellular’s investment in Cell C. (2) The cost basis is zero ($ 0.0 million). 11 2. Accounts receivable, net and other receivables and finance loans receivable, net (continued) Finance loans receivable, net The Company’s finance loans receivable, net, as of March 31, 2024, and June 30, 2023, is presented in the table below: March 31, June 30, 2024 2023 Microlending finance loans receivable, net $ 25,246 $ 20,605 Microlending finance loans receivable, gross 27,000 22,037 Allowance for doubtful finance loans receivable, end of period 1,754 1,432 Beginning of period 1,432 1,394 Reversed to statement of operations ( 149 ) - Charged to statement of operations 1,692 1,452 Utilized ( 1,217 ) ( 1,214 ) Foreign currency adjustment ( 4 ) ( 200 ) Merchant finance loans receivable, net 15,508 16,139 Merchant finance loans receivable, gross 18,273 18,289 Allowance for doubtful finance loans receivable, end of period 2,765 2,150 Beginning of period 2,150 297 Reallocation from allowance for doubtful accounts receivable - 418 Reversed to statement of operations ( 201 ) ( 1,268 ) Charged to statement of operations 1,797 3,068 Utilized ( 978 ) - Foreign currency adjustment ( 3 ) ( 365 ) Total finance loans receivable, net $ 40,754 $ 36,744 Total finance loans receivable, net, comprises microlending finance loans receivable related to the Company’s microlending operations in South Africa as well as its merchant finance loans receivable related to Connect’s lending activities in South Africa. Certain merchant finance loans receivable with an aggregate balance of $ 15.2 million as of March 31, 2024 have been pledged as security for the Company’s revolving credit facility (refer to Note 8). Allowance for credit losses Microlending finance loans receivable Microlending finance loans receivable related to the Company’s microlending operations in South Africa whereby it provides unsecured short-term loans to qualifying customers. Loans to customers have a tenor of up to six months , with the majority of loans originated having a tenor of six months . The Company analyses this lending book as a single portfolio because the loans within the portfolio have similar characteristics and management uses similar processes to monitor and assess the credit risk of the lending book. Refer to Note 4 related to the Company risk management process related to these receivables. The Company has operated this lending book for more than five years and uses historical default experience over the lifetime of loans in order to calculate a lifetime loss rate for the lending book. The allowance for credit losses related to these microlending finance loans receivables is calculated by multiplying the lifetime loss rate with the month end outstanding lending book. The lifetime loss rate as of each of July 1, 2023 and March 31, 2024, was 6.50 %. The performing component (that is, outstanding loan payments not in arrears) of the book exceeds more than 98 % of outstanding lending book as of March 31, 2024. Merchant finance loans receivable Merchant finance loans receivable related to the Company’s Merchant lending activities in South Africa whereby it provides unsecured short-term loans to qualifying customers. Loans to customers have a tenor of up to twelve months , with the majority of loans originated having a tenor of approximately eight months . The Company analyses this lending book as a single portfolio because the loans within the portfolio have similar characteristics and management uses similar processes to monitor and assess the credit risk of the lending book. Refer to Note 4 related to the Company risk management process related to these receivables. 12 2. Accounts receivable, net and other receivables and finance loans receivable, net (continued) Finance loans receivable, net (continued) Allowance for credit losses (continued) Merchant finance loans receivable (continued) The Company has recently (in the past two years ) commenced lending to merchant customers and uses historical default experience over the lifetime of loans generated thus far in order to calculate a lifetime loss rate for the lending book. The allowance for credit losses related to these merchant finance loans receivables is calculated by adding together actual receivables in default plus multiplying the lifetime loss rate with the month-end outstanding lending book. The lifetime loss rate as of each of July 1, 2023 and March 31, 2024, was approximately 1.18 %. The performing component (that is, outstanding loan payments not in arrears), under- performing component (that is, outstanding loan payments that are in arrears) and non-performing component (that is, outstanding loans for which payments appeared to have ceased) of the book represents approximately 84 %, 14 % and 2 %, respectively, of the outstanding lending book as of March 31, 2024. 3. Inventory The Company’s inventory comprised the following categories as of March 31, 2024, and June 30, 2023: March 31, June 30, 2024 2023 Raw materials $ 2,437 $ 2,819 Work-in-progress 299 30 Finished goods 19,053 24,488 $ 21,789 $ 27,337 As of March 31, 2024 and June 30, 2023, finished goods includes $ 6.0 million and $ 8.6 million, respectively, of Cell C airtime inventory that was previously classified as finished goods subject to sale restrictions. In support of Cell C’s liquidity position and pursuant to Cell C’s recapitalization process, the Company limited the resale of this airtime to its own distribution channels. On September 30, 2022, Cell C concluded its recapitalization process and the Company and Cell C entered into an agreement under which Cell C agreed to repurchase, from October 2023, up to ZAR 10 million of Cell C inventory from the Company per month. The amount to be repurchased by Cell C is calculated as ZAR 10 million less the face value of any sales made by the Company during that month. The Company’s ability to sell this airtime has increased significantly since the acquisition of Connect because Connect is a significant reseller of Cell C airtime. As a result, the Company has sold higher volumes of airtime through this channel than it did prior to the Cell C recapitalization, however, continued sales at these volumes is dependent on prevailing conditions continuing in the airtime market. If the Company is able to sell at least ZAR 10 million a month through this channel from October 1, 2023, then Cell C would not be required to repurchase any airtime from the Company during any specific month. The Company has agreed to notify Cell C prior to selling any of this airtime, however, there is no restriction placed on the Company on the sale of the airtime . 13 4. Fair value of financial instruments Initial recognition and measurement Financial instruments are recognized when the Company becomes a party to the transaction. Initial measurements are at cost, which includes transaction costs. Risk management The Company manages its exposure to currency exchange, translation, interest rate, credit, microlending credit and equity price and liquidity risks as discussed below. Currency exchange risk The Company is subject to currency exchange risk because it purchases components for its safe assets, that the Company assembles, and inventories that it is required to settle in other currencies, primarily the euro, renminbi, and U.S. dollar. The Company has used forward contracts in order to limit its exposure in these transactions to fluctuations in exchange rates between the South African rand (“ZAR”), on the one hand, and the U.S. dollar and the euro, on the other hand. Translation risk Translation risk relates to the risk that the Company’s results of operations will vary significantly as the U.S. dollar is its reporting currency, but it earns a significant amount of its revenues and incurs a significant amount of its expenses in ZAR. The U.S. dollar to the ZAR exchange rate has fluctuated significantly over the past three years. As exchange rates are outside the Company’s control, there can be no assurance that future fluctuations will not adversely affect the Company’s results of operations and financial condition. Interest rate risk As a result of its normal borrowing activities, the Company’s operating results are exposed to fluctuations in interest rates, which it manages primarily through regular financing activities. Interest rates in South Africa have been trending upwards in recent quarters but have now stabilized and are expected to remain at current levels, or perhaps even decline moderately over calendar 2024. Therefore, ignoring the impact of changes to the margin on its borrowings (refer to Note 8), the Company expects its cost of borrowing to remain stable, or even to decline moderately, in the foreseeable future, however if the upward trend resumes the Company would expect higher interest rates in the future which will increase its cost of borrowing. The Company periodically evaluates the cost and effectiveness of interest rate hedging strategies to manage this risk. The Company generally maintains surplus cash in cash equivalents and held to maturity investments and has occasionally invested in marketable securities . Credit risk Credit risk relates to the risk of loss that the Company would incur as a result of non-performance by counterparties. The Company maintains credit risk policies in respect of its counterparties to minimize overall credit risk. These policies include an evaluation of a potential counterparty’s financial condition, credit rating, and other credit criteria and risk mitigation tools as the Company’s management deems appropriate. With respect to credit risk on financial instruments, the Company maintains a policy of entering into such transactions only with South African and European financial institutions that have a credit rating of “B” (or its equivalent) or better, as determined by credit rating agencies such as Standard & Poor’s, Moody’s and Fitch Ratings. Consumer microlending credit risk The Company is exposed to credit risk in its Consumer microlending activities, which provides unsecured short-term loans to qualifying customers. Credit bureau checks as well as an affordability test are conducted as part of the origination process, both of which are in line with local regulations. The Company considers this policy to be appropriate because the affordability test it performs takes into account a variety of factors such as other debts and total expenditures on normal household and lifestyle expenses. Additional allowances may be required should the ability of its customers to make payments when due deteriorate in the future. A significant amount of judgment is required to assess the ultimate recoverability of these finance loan receivables, including ongoing evaluation of the creditworthiness of each customer. Merchant lending The Company maintains an allowance for doubtful finance loans receivable related to its Merchant services segment with respect to short-term loans to qualifying merchant customers. The Company’s risk management procedures include adhering to its proprietary lending criteria which uses an online-system loan application process, obtaining necessary customer transaction-history data and credit bureau checks. The Company considers these procedures to be appropriate because it takes into account a variety of factors such as the customer’s credit capacity and customer-specific risk factors when originating a loan. 14 4. Fair value of financial instruments (continued) Risk management (continued) Equity price and liquidity risk Equity price risk relates to the risk of loss that the Company would incur as a result of the volatility in the exchange-traded price of equity securities that it holds. The market price of these securities may fluctuate for a variety of reasons and, consequently, the amount that the Company may obtain in a subsequent sale of these securities may significantly differ from the reported market value. Equity liquidity risk relates to the risk of loss that the Company would incur as a result of the lack of liquidity on the exchange on which those securities are listed. The Company may not be able to sell some or all of these securities at one time, or over an extended period of time without influencing the exchange-traded price, or at all. Financial instruments The following section describes the valuation methodologies the Company uses to measure its significant financial assets and liabilities at fair value. In general, and where applicable, the Company uses quoted prices in active markets for identical assets or liabilities to determine fair value. This pricing methodology would apply to Level 1 investments. If quoted prices in active markets for identical assets or liabilities are not available to determine fair value, then the Company uses quoted prices for similar assets and liabilities or inputs other than the quoted prices that are observable either directly or indirectly. These investments would be included in Level 2 investments. In circumstances in which inputs are generally unobservable, values typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model- based techniques that include option pricing models, discounted cash flow models, and similar techniques. Investments valued using such techniques are included in Level 3 investments. Asset measured at fair value using significant unobservable inputs – investment in Cell C The Company’s Level 3 asset represents an investment of 75,000,000 class “A” shares in Cell C, a significant mobile telecoms provider in South Africa. The Company used a discounted cash flow model developed by the Company to determine the fair value of its investment in Cell C as of March 31, 2024 and June 30, 2023, respectively, and valued Cell C at $ 0.0 (zero) and $ 0.0 (zero) as of March 31, 2024, and June 30, 2023, respectively. The Company incorporates the payments under Cell C’s lease liabilities into the cash flow forecasts and assumes that Cell C’s deferred tax assets would be utilized over the forecast period. The Company has increased the marketability discount from 10 % to 20 % and the minority discount from 15 % to 24 % due to the reduction in the Company’s shareholding percentage from 15 % to 5 % as well as current market conditions. The Company utilized the latest revised business plan provided by Cell C management for the period ended December 31, 2027, for the March 31, 2024, and June 30, 2023, valuations. Adjustments have been made to the WACC rate to reflect the Company’s assessment of risk to Cell C achieving its business plan. The following key valuation inputs were used as of March 31, 2024 and June 30, 2023: Weighted Average Cost of Capital ("WACC"): Between 20 % and 26 % over the period of the forecast Long term growth rate: 4.5 % ( 4.5 % as of June 30, 2023) Marketability discount: 20 % ( 20 % as of June 30, 2023) Minority discount: 24 % ( 24 % as of June 30, 2023) Net adjusted external debt - March 31, 2024: (1) ZAR 7.4 billion ($ 0.4 billion), no lease liabilities included Net adjusted external debt - June 30, 2023: (2) ZAR 8.1 billion ($ 0.4 billion), no lease liabilities included (1) translated from ZAR to U.S. dollars at exchange rates applicable as of March 31, 2024. (2) translated from ZAR to U.S. dollars at exchange rates applicable as of June 30, 2023. The following table presents the impact on the carrying value of the Company’s Cell C investment of a 1.0% decrease and 1.0% increase in the WACC rate and the EBITDA margins respectively used in the Cell C valuation on March 31, 2024, all amounts translated at exchange rates applicable as of March 31, 2024: Sensitivity for fair value of Cell C investment 1.0% increase 1.0% decrease WACC rate $ - $ 553 EBITDA margin $ 1,241 $ - The fair value of the Cell C shares as of March 31, 2024, represented 0 % of the Company’s total assets, including these shares. The Company expects to hold these shares for an extended period of time and that there will be short-term equity price volatility with respect to these shares particularly given that Cell C remains in a turnaround process. 15 4. Fair value of financial instruments (continued) Financial instruments (continued) Derivative transactions - Foreign exchange contracts As part of the Company’s risk management strategy, the Company enters into derivative transactions to mitigate exposures to foreign currencies using foreign exchange contracts. These foreign exchange contracts are over-the-counter derivative transactions. Substantially all of the Company’s derivative exposures are with counterparties that have long-term credit ratings of “B” (or equivalent) or better. The Company uses quoted prices in active markets for similar assets and liabilities to determine fair value (Level 2). The Company has no derivatives that require fair value measurement under Level 1 or 3 of the fair value hierarchy. The Company had no outstanding foreign exchange contracts as of March 31, 2024, and June 30, 2023. The following table presents the Company’s assets measured at fair value on a recurring basis as of March 31, 2024, according to the fair value hierarchy: Quoted Price in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Investment in Cell C $ - $ - $ - $ - Related to insurance business: Cash, cash equivalents and restricted cash (included in other long-term assets) 213 - - 213 Fixed maturity investments (included in cash and cash equivalents) 4,963 - - 4,963 Total assets at fair value $ 5,176 $ - $ - $ 5,176 The following table presents the Company’s assets measured at fair value on a recurring basis as of June 30, 2023, according to the fair value hierarchy: Quoted Price in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Investment in Cell C $ - $ - $ - $ - Related to insurance business Cash and cash equivalents (included in other long-term assets) 258 - - 258 Fixed maturity investments (included in cash and cash equivalents) 3,119 - - 3,119 Total assets at fair value $ 3,377 $ - $ - $ 3,377 There have been no transfers in or out of Level 3 during the three and nine months ended March 31, 2024 and 2023, respectively. There was no movement in the carrying value of assets measured at fair value on a recurring basis, and categorized within Level 3, during the nine months ended March 31, 2024 and 2023. 16 4. Fair value of financial instruments (continued) Summarized below is the movement in the carrying value of assets and liabilities measured at fair value on a recurring basis, and categorized within Level 3, during the nine months ended March 31, 2024: Carrying value Assets Balance as of June 30, 2023 $ - Foreign currency adjustment (1) - Balance as of March 31, 2024 $ - (1) The foreign currency adjustment represents the effects of the fluctuations of the South African rand against the U.S. dollar on the carrying value. Summarized below is the movement in the carrying value of assets and liabilities measured at fair value on a recurring basis, and categorized within Level 3, during the nine months ended March 31, 2023: Carrying value Assets Balance as of June 30, 2022 $ - Foreign currency adjustment (1) - Balance as of March 31, 2023 $ - (1) The foreign currency adjustment represents the effects of the fluctuations of the South African rand against the U.S. dollar on the carrying value. Assets measured at fair value on a nonrecurring basis The Company measures equity investments without readily determinable fair values at fair value on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available and may include quoted market prices, market comparables, and discounted cash flow projections. An impairment charge is recorded when the cost of the asset exceeds its fair value and the excess is determined to be other-than-temporary. Refer to Note 5 for impairment charges recorded during the reporting periods presented herein. The Company has no liabilities that are measured at fair value on a nonrecurring basis. 5. Equity-accounted investments and other long-term assets Refer to Note 9 to the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the year ended June 30, 2023, for additional information regarding its equity-accounted investments and other long-term assets. Equity-accounted investments The Company’s ownership percentage in its equity-accounted investments as of March 31, 2024, and June 30, 2023, was as follows: March 31, June 30, 2024 2023 Finbond Group Limited (“Finbond”) - % 27.8 % Sandulela Technology (Pty) Ltd ("Sandulela") 49.0 % 49.0 % SmartSwitch Namibia (Pty) Ltd (“SmartSwitch Namibia”) 50.0 % 50.0 % Finbond In December 2023, the Company sold its entire remaining equity interest in Finbond which comprised of 220,523,358 shares, and which represented approximately 27.8 % of Finbond’s issued and outstanding ordinary shares immediately prior to the sale. 17 5. Equity-accounted investments and other long-term assets (continued) Equity-accounted investments (continued) Finbond (continued) August 2023 agreement to sell entire stake in Finbond On August 10, 2023, the Company, through its wholly owned subsidiary Net1 Finance Holdings (Pty) Ltd, entered into an agreement with Finbond to sell its remaining shareholding to Finbond for a cash consideration of ZAR 64.2 million ($ 3.5 million), or ZAR 0.2911 per share. The transaction was subject to certain conditions, including regulatory and shareholder approvals, which were finalized in December 2023. The Company did no t record a gain or loss on the disposal because the sale proceeds were equivalent to the net carrying value, including accumulated reserves, of the investment in Finbond as of the disposal date. The cash proceeds received of ZAR 64.2 million ($ 3.5 million) were used to repay capitalized interest under our borrowing facilities, refer to Note 8. Sale of Finbond shares during the three and nine months ended March 31, 2023 The Company sold 17,357,346 and 24,818,937 shares in Finbond for cash during the three and nine months ended March 31, 2023, respectively, and recorded a loss of $ 0.3 million and $ 0.4 million, which is included in the caption net gain on disposal of equity- accounted investments in the Company’s unaudited condensed consolidated statements of operations. The following table presents the calculation of the loss on disposal of Finbond shares during the three and nine months ended March 31, 2024 and 2023: Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 Loss on disposal of Finbond shares: Consideration received in cash $ - $ 254 $ 3,508 $ 395 Less: carrying value of Finbond shares sold - ( 349 ) ( 2,112 ) ( 509 ) Less: release of foreign currency translation reserve from accumulated other comprehensive loss - ( 243 ) ( 1,543 ) ( 342 ) Add: release of stock-based compensation charge related to equity-accounted investment - 9 147 13 Loss on sale of Finbond shares $ - $ ( 329 ) $ - $ ( 443 ) Finbond impairments recorded during the nine months ended March 31, 2024 As noted earlier, the Company has entered into an agreement to exit its position in Finbond and the Company considered this an impairment indicator. The Company is required to include any foreign currency translation reserve and other equity account amounts in its impairment assessment if it considers exiting an equity method investment. The Company performed an impairment assessment of its holding in Finbond, including the foreign currency translation reserve and other equity account amounts, as of September 30, 2023. The Company recorded an impairment loss of $ 1.2 million during the quarter ended September 30, 2023, which represented the difference between the determined fair value of the Company’s interest in Finbond and the Company’s carrying value, including the foreign currency translation reserve (before the impairment). The Company used the price of ZAR 0.2911 referenced in the August 2023 agreement referred to above to calculate the determined fair value for Finbond. Finbond impairments recorded during the nine months ended March 31, 2023 The Company considered the combination of the ongoing losses incurred and reported by Finbond and its lower share price as impairment indicators. The Company performed an impairment assessment of its holding in Finbond as of September 30, 2022. The Company recorded an impairment loss of $ 1.1 million during the quarter ended September 30, 2022, related to the other-than- temporary decrease in Finbond’s value, which represented the difference between the determined fair value of the Company’s interest in Finbond and the Company’s carrying value (before the impairment). The Company observed continued limited trading in Finbond shares on the JSE during the three months ended September 30, 2022, because a small number of shareholders owned approximately 80 % of its issued and outstanding shares between them. The Company calculated a fair value per share for Finbond by applying a liquidity discount of 25 % to the September 30, 2022, Finbond closing price of ZAR 0.49 . The Company increased the liquidity discount from 15 % (used in the previous impairment assessment) to 25 % as a result of the ongoing limited trading activity observed on the JSE. 18 5. Equity-accounted investments and other long-term assets (continued) Equity-accounted investments (continued) Carbon In September 2022, the Company, through its wholly-owned subsidiary, Net1 Applied Technologies Netherlands B.V. (“Net1 BV”), entered into a binding term sheet with the Etobicoke Limited (“Etobicoke”) to sell its entire interest, or 25 %, in Carbon to Etobicoke for $ 0.5 million and a loan due from Carbon, with a face value of $ 3.0 million, to Etobicoke for $ 0.75 million. Both the equity interest and the loan had a carrying value of $ 0 (zero) at June 30, 2022. The parties have agreed that Etobicoke pledge the Carbon shares purchased as security for the amounts outstanding under the binding term sheet. The Company received $ 0.25 million on closing and the outstanding balance due by Etobicoke was expected to be paid as follows: (i) $ 0.25 million on September 30, 2023 (the amount was received in October 2023), and (ii) the remaining amount, of $ 0.75 million in March 2024 (the amount has not been received as of March 31, 2024 (refer to Note 2)). Both amounts were included in the caption accounts receivable, net and other receivables in the Company’s unaudited condensed consolidated balance sheet as of June 30, 2023. The Company has allocated the $ 0.25 million received on closing to the sale of the equity interest and allocated the subsequent funds received first to the sale of the equity interest and then to the loans. The Company believed that the fair value of the Carbon shares provided as security was $ 0 (zero), which was in line with the carrying value as of June 30, 2022, and created an allowance for doubtful loans receivable related to the $ 1.0 million previously due from Etobicoke. The Company did not incur any significant transaction costs. The Company has included the gain of $ 0.25 million related to the sale of the Carbon equity interest in the caption net gain on disposal of equity-accounted investments in the Company’s unaudited condensed consolidated statements of operations. The following table presents the calculation of the gain on disposal of Carbon in September 2022: Three months ended September 30, 2022 Gain on disposal of Carbon shares: Consideration received in cash in September 2022 $ 250 Less: carrying value of Carbon - Gain on disposal of Carbon shares: (1) $ 250 (1) The Company does not expect to pay taxes related to the sale of Carbon because the base cost of its investment exceeds the sales consideration received. The Company does not believe that it will be able to utilize the loss generated because Net1 BV does not generate taxable income. Summarized below is the movement in equity-accounted investments and loans provided to equity-accounted investments during the nine months ended March 31, 2024: Finbond Other (1) Total Investment in equity Balance as of June 30, 2023 $ 3,040 $ 131 $ 3,171 Stock-based compensation 14 - 14 Comprehensive income: ( 956 ) 126 ( 830 ) Other comprehensive income 489 - 489 Equity accounted (loss) earnings ( 1,445 ) 126 ( 1,319 ) Share of net (loss) earnings ( 278 ) 126 ( 152 ) Impairment ( 1,167 ) - ( 1,167 ) Dividends received - ( 95 ) ( 95 ) Disposal of Finbond shares ( 2,096 ) - ( 2,096 ) Foreign currency adjustment (2) ( 2 ) ( 3 ) ( 5 ) Balance as of March 31, 2024 $ - $ 159 $ 159 (1) Includes Sandulela, and SmartSwitch Namibia; (2) The foreign currency adjustment represents the effects of the fluctuations of the ZAR and Namibian dollar, against the U.S. dollar on the carrying value. 19 5. Equity-accounted investments and other long-term assets (continued) Other long-term assets Summarized below is the breakdown of other long-term assets as of March 31, 2024, and June 30, 2023: March 31, June 30, 2024 2023 Total equity investments $ 76,297 $ 76,297 Investment in 5 % of Cell C (June 30, 2023: 5 %) at fair value (Note 4) - - Investment in 10 % of MobiKwik (June 30, 2023: 10 %) (1) 76,297 76,297 Investment in 87.5 % of CPS (June 30, 2023: 87.5 %) at fair value (1)(2) - - Policy holder assets under investment contracts (Note 7) 213 257 Reinsurance assets under insurance contracts (Note 7) 1,525 1,040 Total other long-term assets $ 78,035 $ 77,594 (1) The Company determined that MobiKwik and CPS do not have readily determinable fair values and therefore elected to record these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. (2) On October 16, 2020, the High Court of South Africa, Gauteng Division, Pretoria ordered that CPS be placed into liquidation. Summarized below are the components of the Company’s equity securities without readily determinable fair value and held to maturity investments as of March 31, 2024: Cost basis Unrealized holding Unrealized holding Carrying gains losses value Equity securities: Investment in MobiKwik $ 26,993 $ 49,304 $ - $ 76,297 Investment in CPS - - - - Held to maturity: Investment in Cedar Cellular notes (Note 2) - - - - Total $ 26,993 $ 49,304 $ - $ 76,297 Summarized below are the components of the Company’s equity securities without readily determinable fair value and held to maturity investments as of June 30, 2023: Cost basis Unrealized holding Unrealized holding Carrying gains losses value Equity securities: Investment in MobiKwik $ 26,993 $ 49,304 $ - $ 76,297 Investment in CPS - - - - Held to maturity: Investment in Cedar Cellular notes - - - - Total $ 26,993 $ 49,304 $ - $ 76,297 20 6. Goodwill and intangible assets, net Goodwill Summarized below is the movement in the carrying value of goodwill for the nine months ended March 31, 2024: Gross value Accumulated impairment Carrying value Balance as of June 30, 2023 $ 152,619 $ ( 18,876 ) $ 133,743 Foreign currency adjustment (1) ( 297 ) 27 ( 270 ) Balance as of March 31, 2024 $ 152,322 $ ( 18,849 ) $ 133,473 (1) – The foreign currency adjustment represents the effects of the fluctuations of the South African rand against the U.S. dollar on the carrying value. Goodwill has been allocated to the Company’s reportable segments as follows: Consumer Merchant Carrying value Balance as of June 30, 2023 $ - $ 133,743 $ 133,743 Foreign currency adjustment (1) - ( 270 ) ( 270 ) Balance as of March 31, 2024 $ - $ 133,473 $ 133,473 (1) The foreign currency adjustment represents the effects of the fluctuations of the South African rand against the U.S. dollar on the carrying value. Intangible assets, net Carrying value and amortization of intangible assets Summarized below is the carrying value and accumulated amortization of intangible assets as of March 31, 2024, and June 30, 2023: As of March 31, 2024 As of June 30, 2023 Gross carrying value Accumulated amortization Net carrying value Gross carrying value Accumulated amortization Net carrying value Finite-lived intangible assets: Customer relationships $ 24,927 $ ( 13,021 ) $ 11,906 $ 24,978 $ ( 11,565 ) $ 13,413 Software, integrated platform and unpatented technology 110,914 ( 22,026 ) 88,888 110,906 ( 13,711 ) 97,195 FTS patent 2,030 ( 2,030 ) - 2,034 ( 2,034 ) - Brands and trademarks 13,824 ( 3,820 ) 10,004 13,852 ( 2,863 ) 10,989 Total finite-lived intangible assets $ 151,695 $ ( 40,897 ) $ 110,798 $ 151,770 $ ( 30,173 ) $ 121,597 Aggregate amortization expense on the finite-lived intangible assets for the three months ended March 31, 2024 and 2023, was $ 3.6 million and $ 3.8 million, respectively. Aggregate amortization expense on the finite-lived intangible assets for the nine months ended March 31, 2024 and 2023, was $ 10.8 million and $ 11.6 million, respectively. Future estimated annual amortization expense for the next five fiscal years and thereafter, assuming exchange rates that prevailed on March 31, 2024, is presented in the table below. Actual amortization expense in future periods could differ from this estimate as a result of acquisitions, changes in useful lives, exchange rate fluctuations and other relevant factors. Fiscal 2024 (three months ended March 31, 2024) $ 3,594 Fiscal 2025 14,382 Fiscal 2026 14,382 Fiscal 2027 14,327 Fiscal 2028 14,295 Thereafter 49,818 Total future estimated annual amortization expense $ 110,798 21 7. Assets and policyholder liabilities under insurance and investment contracts Reinsurance assets and policyholder liabilities under insurance contracts Summarized below is the movement in reinsurance assets and policyholder liabilities under insurance contracts during the nine months ended March 31, 2024: Reinsurance Assets (1) Insurance contracts (2) Balance as of June 30, 2023 $ 1,040 $ ( 1,600 ) Increase in policy holder benefits under insurance contracts 809 ( 5,498 ) Claims and decrease in policyholders’ benefits under insurance contracts ( 319 ) 4,833 Foreign currency adjustment (3) ( 5 ) 8 Balance as of March 31, 2024 $ 1,525 $ ( 2,257 ) (1) Included in other long-term assets (refer to Note 5); (2) Included in other long-term liabilities; (3) Represents the effects of the fluctuations of the ZAR against the U.S. dollar. The Company has agreements with reinsurance companies in order to limit its losses from various insurance contracts, however, if the reinsurer is unable to meet its obligations, the Company retains the liability. The value of insurance contract liabilities is based on the best estimate assumptions of future experience plus prescribed margins, as required in the markets in which these products are offered, namely South Africa. The process of deriving the best estimate assumptions plus prescribed margins includes assumptions related to claim reporting delays (based on average industry experience). Assets and policyholder liabilities under investment contracts Summarized below is the movement in assets and policyholder liabilities under investment contracts during the nine months ended March 31, 2024: Assets (1) Investment contracts (2) Balance as of June 30, 2023 $ 257 $ ( 241 ) Increase in policy holder benefits under investment contracts 8 ( 8 ) Claims and decrease in policyholders’ benefits under investment contracts ( 44 ) 44 Foreign currency adjustment (3) ( 8 ) ( 8 ) Balance as of March 31, 2024 $ 213 $ ( 213 ) (1) Included in other long-term assets (refer to Note 5); (2) Included in other long-term liabilities; (3) Represents the effects of the fluctuations of the ZAR against the U.S. dollar. The Company does not offer any investment products with guarantees related to capital or returns. 8. Borrowings Refer to Note 12 to the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the year ended June 30, 2023, for additional information regarding its borrowings. South Africa The amounts below have been translated at exchange rates applicable as of the dates specified. The 3-month Johannesburg Interbank Agreed Rate (“JIBAR”), the rate at which private sector banks borrow funds from the South African Reserve Bank, on March 31, 2024, was 8.35 %. The prime rate, the benchmark rate at which private sector banks lend to the public in South Africa, on March 31, 2024, was 11.75 %. 22 8. Borrowings (borrowings) South Africa (continued) RMB Facilities, as amended, comprising a short-term facility (Facility E) and long-term borrowings Long-term borrowings - Facility G and Facility H As of March 31, 2024, the Company had not utilized any of its ZAR 200 million Facility G revolving credit facility. The interest rate on this facility as of March 31, 2024, was JIBAR plus 5.50 %. On November 24, 2023, the Company, through its wholly owned subsidiary, Lesaka Technologies Proprietary Limited (“Lesaka SA”), entered into an Amendment and Restatement Agreement (the “Amendment”), which includes an Amended and Restated Senior Facility G Agreement (“Facility G Agreement”) and an Amended and Restated Senior Facility H Agreement (“Facility H Agreement”) (collectively, the “Loan Documents”) with FirstRand Bank Limited (acting through its Rand Merchant Bank division) (“RMB” or the “Lenders”). The Loan Documents were amended to include a Look Through Leverage (“LTL”) ratio, as defined in the Loan Documents, and expressed as times (“x”), to calculate the margin used in the determination of the interest rate. The LTL ratio is calculated as the Total Attributable Net Debt, as defined in the Loan Documents, to the Total Attributable EBITDA, as defined in the Loan Documents, for the measurement period ending on a specified date. Interest on Facility G and Facility H is based on the JIBAR in effect from time to time plus a margin, which as a result of the Amendment, from October 1, 2023, will be calculated as: (i) 5.50 % if the LTL ratio is greater than 3.50x; (ii) 4.75 % if the LTL ratio is less than 3.50x but greater than 2.75x; (iii) 3.75 % if the LTL ratio is less than 2.75x but greater than 1.75x; or (iv) 2.50 % if the LTL ratio is less than 1.75x. The Company used cash proceeds of ZAR 64.2 million ($ 3.5 million) received from the sale of Finbond shares (refer to Note 5) during the nine months ended March 31, 2024, to repay capitalized interest under Facility G and Facility H. Available short-term facility - Facility E As of March 31, 2024, the aggregate amount of the Company’s short-term South African overdraft facility with RMB was ZAR 0.9 billion ($ 47.7 million). As of March 31, 2024, the Company had utilized ZAR 0.1 billion ($ 4.3 million) of this overdraft facility. This overdraft facility may only be used to fund ATMs and therefore the overdraft utilized and converted to cash to fund the Company’s ATMs is considered restricted cash. The interest rate on this facility is equal to the prime rate. Connect Facilities, comprising long-term borrowings and a short-term facility As of March 31, 2024, the Connect Facilities include (i) an overdraft facility (general banking facility) of ZAR 205.0 million (of which ZAR 170.0 million has been utilized); (ii) Facility A of ZAR 700.0 million; (iii) Facility B of ZAR 550.0 million (both fully utilized); and (iv) an asset-backed facility of ZAR 200.0 million (of which ZAR 154.6 million has been utilized). CCC Revolving Credit Facility, comprising long-term borrowings As of March 31, 2024, the amount of the CCC Revolving Credit Facility was ZAR 300.0 million (of which ZAR 241.0 million has been utilized). Interest on the Revolving Credit Facility is payable on the last business day of each calendar month and is based on the South African prime rate in effect from time to time plus a margin of 0.95 % per annum. RMB facility, comprising indirect facilities As of March 31, 2024, the aggregate amount of the Company’s short-term South African indirect credit facility with RMB was ZAR 135.0 million ($ 7.1 million), which includes facilities for guarantees, letters of credit and forward exchange contracts. As of March 31, 2024 and June 30, 2023, the Company had utilized ZAR 33.1 million ($ 1.8 million) and ZAR 33.1 million ($ 1.8 million), respectively, of its indirect and derivative facilities of ZAR 135.0 million (June 30, 2023: ZAR 135.0 million) to enable the bank to issue guarantees, letters of credit and forward exchange contracts (refer to Note 19). 23 8. Borrowings (borrowings) South Africa (continued) Nedbank facility, comprising short-term facilities As of March 31, 2024, the aggregate amount of the Company’s short-term South African credit facility with Nedbank Limited was ZAR 156.6 million ($ 8.3 million). The credit facility represents indirect and derivative facilities of up to ZAR 156.6 million ($ 8.3 million), which include guarantees, letters of credit and forward exchange contracts. As of March 31, 2024 and June 30, 2023, the Company had utilized ZAR 2.1 million ($ 0.1 million) and ZAR 2.1 million ($ 0.1 million), respectively, of its indirect and derivative facilities of ZAR 156.6 million (June 30, 2023: ZAR 156.6 million) to enable the bank to issue guarantees, letters of credit and forward exchange contracts (refer to Note 19). Movement in short-term credit facilities Summarized below are the Company’s short-term facilities as of March 31, 2024, and the movement in the Company’s short- term facilities from as of June 30, 2023 to as of March 31, 2024: RMB RMB RMB Nedbank Facility E Indirect Connect Facilities Total Short-term facilities available as of March 31, 2023 $ 47,680 $ 7,152 $ 10,860 $ 8,294 $ 73,986 Overdraft - - 10,860 - 10,860 Overdraft restricted as to use for ATM funding only 47,680 - - - 47,680 Indirect and derivative facilities - 7,152 - 8,294 15,446 Movement in utilized overdraft facilities: Restricted as to use for ATM funding only 23,021 - - - 23,021 No restrictions as to use - - 9,025 - 9,025 Balance as of June 30, 2023 23,021 - 9,025 - 32,046 Utilized 153,477 - 2 - 153,479 Repaid ( 172,219 ) - ( 2 ) - ( 172,221 ) Foreign currency adjustment (1) ( 7 ) - ( 19 ) - ( 26 ) Balance as of March 31, 2024 4,272 - 9,006 - 13,278 Restricted as to use for ATM funding only 4,272 - - - 4,272 No restrictions as to use $ - $ - $ 9,006 $ - $ 9,006 Interest rate as of March 31, 2024 (%) (2) 11.75 - 11.65 - Movement in utilized indirect and derivative facilities: Balance as of June 30, 2023 $ - $ 1,757 $ - $ 112 $ 1,869 Foreign currency adjustment (1) - ( 3 ) - - ( 3 ) Balance as of March 31, 2024 $ - $ 1,754 $ - $ 112 $ 1,866 (1) Represents the effects of the fluctuations between the ZAR and the U.S. dollar. (2) Facility E interest set at prime and the Connect facility at prime less 0.10 %. 24 8. Borrowings (continued) Movement in long-term borrowings Summarized below is the movement in the Company’s long-term borrowing from as of as of June 30, 2023 to as of March 31, 2024: Facilities G & H A&B CCC Asset backed Total Included in current $ - $ - $ - $ 3,663 $ 3,663 Included in long-term 48,965 64,436 11,802 4,252 129,455 Opening balance as of June 30, 2023 48,965 64,436 11,802 7,915 133,118 Facilities utilized 8,072 - 2,915 3,439 14,426 Facilities repaid ( 7,929 ) - ( 1,968 ) ( 3,154 ) ( 13,051 ) Non-refundable fees paid - - - - - Non-refundable fees amortized 309 36 36 - 381 Capitalized interest 5,420 - - - 5,420 Capitalized interest repaid ( 4,238 ) - - - ( 4,238 ) Foreign currency adjustment (1) ( 232 ) ( 130 ) ( 19 ) ( 8 ) ( 389 ) Closing balance as of March 31, 2024 50,367 64,342 12,766 8,192 135,667 Included in current - - - 3,269 3,269 Included in long-term 50,367 64,342 12,766 4,923 132,398 Unamortized fees ( 292 ) ( 185 ) ( 31 ) - ( 508 ) Due within 2 years - 1,656 - 3,592 5,248 Due within 3 years 50,659 6,953 12,797 1,180 71,589 Due within 4 years - 55,918 - 108 56,026 Due within 5 years $ - $ - $ - $ 43 $ 43 Interest rates as of March 31, 2024 (%): 13.10 12.10 12.70 12.50 Base rate (%) 8.35 8.35 11.75 11.75 Margin (%) 4.75 3.75 0.95 0.75 Footnote number (2) (3) (4) (5) (1) Represents the effects of the fluctuations between the ZAR and the U.S. dollar. (2) Interest on Facility G and Facility H was calculated based on the 3-month JIBAR in effect from time to time plus a margin of, from January 1, 2023 to September 30, 2023: (i) 5.50 % for as long as the aggregate balance under the Facilities is greater than ZAR 800 million; (ii) 4.25 % if the aggregate balance under the Facilities is equal to or less than ZAR 800 million, but greater than ZAR 350 million; or (iii) 2.50 % if the aggregate balance under the Facilities is less than ZAR 350 million. From October 1, 2023, interest is calculated as described above. (3) Interest on Facility A and Facility B is calculated based on JIBAR plus a margin, of 3.75 %, in effect from time to time. (4) Interest is charged at prime plus 0.95 % per annum on the utilized balance. (5) Interest is charged at prime plus 0.75 % per annum on the utilized balance. Interest expense incurred under the Company’s South African long-term borrowings and included in the caption interest expense on the condensed consolidated statement of operations during the three months ended March 31, 2024 and 2023, was $ 4.0 million and $ 3.0 million, respectively. Prepaid facility fees amortized included in interest expense during the three months ended March 31, 2024 and 2023, respectively, were $ 0.1 million and $ 0.2 million, respectively. Interest expense incurred under the Company’s K2020 and CCC facilities relates to borrowings utilized to fund a portion of the Company’s merchant finance loans receivable and this interest expense of $ 0.4 million and $ 0.3 million, respectively, is included in the caption cost of goods sold, IT processing, servicing and support on the condensed consolidated statement of operations for the three months ended March 31, 2024 and 2023. Interest expense incurred during the nine months ended March 31, 2024 and 2023, was $ 12.1 million and $ 5.7 million, respectively. Prepaid facility fees amortized included in interest expense during the nine months ended March 31, 2024 and 2023, respectively, were $ 0.3 million and $ 0.4 million, respectively. Interest expense incurred under the Company’s K2020 and CCC facilities relates to borrowings utilized to fund a portion of the Company’s merchant finance loans receivable and this interest expense of $ 1.1 million and $ 0.5 million, respectively, is included in the caption cost of goods sold, IT processing, servicing and support on the condensed consolidated statement of operations for the nine months ended March 31, 2024 and 2023. 25 9. Other payables Summarized below is the breakdown of other payables as of March 31, 2024, and June 30, 2023: March 31, June 30, 2024 2023 Clearing accounts (1) $ 9,405 $ 4,016 Vendor wallet balances (1) 15,506 9,492 Accruals 8,988 7,078 Provisions 5,590 7,429 Value -added tax payable 1,344 1,247 Payroll-related payables 828 1,038 Participating merchants' settlement obligation 22 39 Other 7,787 5,958 $ 49,470 $ 36,297 (1) Clearing accounts and vendor wallet balances (previously defined as transactions-switching funds payables) as of June 30, 2023, were previously included in Other and have been reclassified to separate captions to conform with presentation as of March 31, 2024. Clearing accounts and vendor wallet balances may fluctuate due to day (weekend or public holiday) on which the Company’s quarter or year end falls because certain elements of transactions within these accounts are not settled over weekends or public holidays. Other includes deferred income, client deposits and other payables. 10. Capital structure Issue of shares to Connect sellers pursuant to April 2022 transaction The total purchase consideration pursuant to the Connect acquisition in April 2022 includes 3,185,079 shares of the Company’s common stock. These shares of common stock will be issued in three equal tranches on each of the first, second and third anniversaries of the April 14, 2022 closing. The Company legally issued 1,061,693 shares of its common stock, representing the second tranche, to the Connect sellers in April 2024, and this had no impact on the number of shares, net of treasury, presented in the unaudited condensed consolidated statement of changes during the nine months ended March 31, 2024 because the 3,185,079 shares are included in the number of shares, net of treasury, as of June 30, 2023, and March 31, 2024. Impact of non-vested equity shares on number of shares, net of treasury The following table presents a reconciliation between the number of shares, net of treasury, presented in the unaudited condensed consolidated statement of changes in equity during the nine months ended March 31, 2024 and 2023, respectively, and the number of shares, net of treasury, excluding non-vested equity shares that have not vested as of March 31, 2024 and 2023, respectively: March 31, March 31, 2024 2023 Number of shares, net of treasury: Statement of changes in equity 64,466,830 63,743,900 Non-vested equity shares that have not vested as of end of period 3,131,469 3,194,463 Number of shares, net of treasury, excluding non-vested equity shares that have not vested 61,335,361 60,549,437 11. Accumulated other comprehensive loss The table below presents the change in accumulated other comprehensive loss per component during the three months ended March 31, 2024: Three months ended March 31, 2024 Accumulated foreign currency translation reserve Total Balance as of January 1, 2024 $ ( 189,378 ) $ ( 189,378 ) Movement in foreign currency translation reserve ( 5,718 ) ( 5,718 ) Balance as of March 31, 2024 $ ( 195,096 ) $ ( 195,096 ) 26 11. Accumulated other comprehensive loss (continued) The table below presents the change in accumulated other comprehensive loss per component during the three months ended March 31, 2023: Three months ended March 31, 2023 Accumulated foreign currency translation reserve Total Balance as of January 1, 2023 $ ( 176,238 ) $ ( 176,238 ) Release of foreign currency translation reserve related to disposal of Finbond equity securities 243 243 Movement in foreign currency translation reserve related to equity-accounted investment 216 216 Movement in foreign currency translation reserve ( 9,775 ) ( 9,775 ) Balance as of March 31, 2023 $ ( 185,554 ) $ ( 185,554 ) The table below presents the change in accumulated other comprehensive loss per component during the nine months ended March 31, 2024: Nine months ended March 31, 2024 Accumulate d foreign currency translation reserve Total Balance as of July 1, 2023 $ ( 195,726 ) $ ( 195,726 ) Release of foreign currency translation reserve related to disposal of Finbond equity securities (Note 5) 1,543 1,543 Release of foreign currency translation reserve related to liquidation of subsidiaries ( 952 ) ( 952 ) Movement in foreign currency translation reserve related to equity-accounted investment 489 489 Movement in foreign currency translation reserve ( 450 ) ( 450 ) Balance as of March 31, 2024 $ ( 195,096 ) $ ( 195,096 ) The table below presents the change in accumulated other comprehensive loss per component during the nine months ended March 31, 2023: a Nine months ended March 31, 2023 Accumulate d foreign currency translation reserve Total Balance as of July 1, 2022 $ ( 168,840 ) $ ( 168,840 ) Release of foreign currency translation reserve related to disposal of Finbond equity securities 342 342 Movement in foreign currency translation reserve related to equity -accounted investment 2,657 2,657 Movement in foreign currency translation reserve ( 19,713 ) ( 19,713 ) Balance as of March 31, 2023 $ ( 185,554 ) $ ( 185,554 ) The movement in the foreign currency translation reserve represents the impact of translation of consolidated entities which have a functional currency (which is primarily ZAR) to the Company’s reporting currency, which is USD. During the nine months ended March 31, 2024, the Company reclassified losses of $ 1.5 million from accumulated other comprehensive loss (accumulated foreign currency translation reserve) to net loss related to the disposal of shares in Finbond (refer to Note 5). During the three and nine months ended March 31, 2023, the Company reclassified losses of $ 0.2 million and $ 0.3 million, respectively, from accumulated other comprehensive loss (accumulated foreign currency translation reserve) to net loss related to the disposal of shares in Finbond. The Company also reclassified a gain of $ 1.0 million from accumulated other comprehensive loss (accumulated foreign currency translation reserve) to net loss related to the liquidation of subsidiaries during the nine months ended March 31, 2024. 27 12. Stock-based compensation The Company’s Amended and Restated 2022 Stock Incentive Plan (“20 22 Plan”) and the vesting terms of certain stock-based awards granted are described in Note 17 to the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the year ended June 30, 2023. Stock option and restricted stock activity Options The following table summarizes stock option activity for the nine months ended March 31, 2024 and 2023: Number of shares Weighted average exercise price ($) Weighted average remaining contractual term (in years) Aggregate intrinsic value ($'000) Weighted average grant date fair value ($) Outstanding - June 30, 2023 673,274 4.37 5.14 239 1.67 Granted - December 2023 500,000 3.50 5.17 880 1.76 Exercised ( 23,217 ) 1.20 - 14 - Forfeited ( 195,739 ) 3.93 - - 1.39 Outstanding - March 31, 2024 954,318 4.03 5.24 45 1.78 Outstanding - June 30, 2022 926,225 4.14 6.60 1,249 1.60 Exercised ( 147,326 ) 3.04 - 190 - Forfeited ( 66,959 ) 3.66 - - - Outstanding - March 31, 2023 711,940 4.41 5.42 670 1.64 The Company awarded 500,000 stock options to Ali Mazanderani, the Company’s Executive Chair, during the nine months ended March 31, 2024. These option s will vest on the first anniversary of the grant date, provided that Mr. Mazandarani continues to provide services as Executive Chair through the vesting date. These options will vest immediately if Mr. Mazanderani’s employment is terminated by the Company without cause on or before the first anniversary of the grant date. These 500,000 stock options may only be exercised during a period commencing from January 31, 2028 to January 31, 2029. No stock options were awarded during the three months ended March 31, 2024, or during the three and nine months ended December 31, 2022. During the three and nine months ended March 31, 2024, the Company received $ 0.05 million and $ 0.07 million from the exercise of 15,832 and 23,217 stock options, respectively. During the three and nine months ended March 31, 2023, an employee delivered 23,934 shares of the Company’s common stock to exercise 37,500 stock options with an aggregate strike price of $ 0.1 million. These 23,934 shares of common stock have been included in the Company’s treasury stock. The employee also elected to deliver 6,105 shares of the Company’s common stock to settle income taxes arising upon exercise of the stock options, and these shares have also been included in the Company’s treasury stock. During the nine months ended March 31, 2023, the Company received approximately $ 0.4 million from the exercise of 147,326 stock options. Employees and a non-employee director forfeited an aggregate of 8,893 and 195,739 stock options during the three and nine months ended March 31, 2024. Employees forfeited 66,959 during each of the three and nine months ended March 31, 2023. The fair value of each option is estimated on the date of grant using the Cox Ross Rubinstein binomial model that uses the assumptions noted in the following table. The estimated expected volatility is calculated based on the Company’s 750-day volatility. The estimated expected life of the option was determined based on the historical behavior of employees who were granted options with similar terms. The table below presents the range of assumptions used to value stock options granted during the nine months ended March 31, 2024 and 2023: Nine months ended March 31, 2024 2023 Expected volatility 56 % 0 % Expected dividends 0 % 0 % Expected life (in years) 5 0 Risk-free rate 2.1 % 0.0 % 28 12. Stock-based compensation (continued) Stock option and restricted stock activity Options The following table presents stock options vested and expected to vest as of March 31, 2024: Number of shares Weighted average exercise price ($) Weighted average remaining contractual term (in years) Aggregate intrinsic value ($’000) Vested and expecting to vest - March 31, 2024 954,318 4.03 5.24 45 These options have an exercise price range of $ 3.01 to $ 11.23 . The following table presents stock options that are exercisable as of March 31, 2024: Number of shares Weighted average exercise price ($) Weighted average remaining contractual term (in years) Aggregate intrinsic value ($’000) Exercisable - March 31, 2024 425,746 4.60 5.69 45 During the three months ended March 31, 2024 and 2023, respectively, 28,569 and 35,649 stock options became exercisable. During the nine months ended March 31, 2024 and 2023, respectively, 116,063 and 327,965 stock options became exercisable. The Company issues new shares to satisfy stock option exercises. 29 12. Stock-based compensation (continued) Stock option and restricted stock activity (continued) Restricted stock The following table summarizes restricted stock activity for the nine months ended March 31, 2024 and 2023: Number of shares of restricted stock Weighted average grant date fair value ($’000) Non-vested – June 30, 2023 2,614,419 11,869 Total granted 934,521 3,622 Granted – October 2023 333,080 1,456 Granted – October 2023, with performance conditions 310,916 955 Granted – October 2023 225,000 983 Granted – January 2024 56,330 197 Granted – February 2024 9,195 31 Total vested ( 339,803 ) 1,274 Vested – July 2023 ( 78,800 ) 302 Vested – November 2023 ( 109,833 ) 429 Vested – December 2023 ( 67,073 ) 234 Vested – February 2024 ( 14,811 ) 53 Vested – March 2024 ( 69,286 ) 256 Forfeitures ( 77,668 ) 278 Non-vested – March 31, 2024 3,131,469 13,434 Non-vested – June 30, 2022 2,385,267 11,879 Total Granted 1,062,153 4,287 Granted – July 2022 32,582 172 Granted – August 2022 179,498 995 Granted – November 2022 150,000 605 Granted – December 2022 430,399 1,862 Granted – December 2022, with performance awards 257,868 596 Granted – January 2023 11,806 57 Total vested ( 234,159 ) 1,098 Vested – July 2022 ( 78,801 ) 410 Vested – November 2022 ( 59,833 ) 250 Vested – December 2022 ( 7,060 ) 29 Vested – February 2023 ( 19,179 ) 83 Vested – March 2023 ( 69,286 ) 326 Total granted and vested - December 2022 - - Granted - December 2022 300,000 1,365 Vested - December 2022 ( 300,000 ) 1,365 Forfeitures ( 18,798 ) 9,235 Non-vested – March 31, 2023 3,194,463 14,822 30 12. Stock-based compensation (continued) Stock option and restricted stock activity (continued) Restricted stock (continued) Grants In October 2023, the Company awarded 333,080 shares of restricted stock with time-based vesting conditions to approximately 150 employees, which are subject to the employees continued employment with the Company through the applicable vesting dates. The Company also awarded 225,000 shares of restricted stock to an executive officer in October 2023, which vest on June 30, 2025, except if the executive officer is terminated for cause, in which case the award will be forfeited. In January 2024, the Company awarded 56,330 shares of restricted stock with time-based vesting conditions to an employee. In October 2023, the Company awarded 310,916 shares of restricted stock to three of its executive officers which are subject to a time-based vesting condition and a market condition and vest in full only on the date, if any, that the following conditions are satisfied: (1) a compounded annual 10 % appreciation in the Company’s stock price off a base price of $ 4.00 over the measurement period commencing on September 30, 2023 through November 17, 2026, and (2) the recipient is employed by the Company on a full- time basis when the condition in (1) is met. If either of these conditions is not satisfied, then none of the shares of restricted stock will vest and they will be forfeited. The Company’s closing price on September 30, 2023, was $ 3.90 . The appreciation levels (times and price) and vesting percentages as of each period ended are as follows: ● Prior to the first anniversary of the grant date: 0 %; ● Fiscal 2025, the Company’s 30-day volume weighted-average stock price (“VWAP”) before November 17, 2024 is approximately 1.10 times higher (i.e. $ 4.40 or higher) than $ 4.00 : 33 %; ● Fiscal 2026, the Company’s VWAP before November 17, 2025 is 1.21 times higher (i.e. $ 4.84 or higher) than $ 4.00 : 67 %; ● Fiscal 2027, the Company’s VWAP before November 1, 2026 is 1.33 times higher (i.e. $ 5.32 ) than $ 4.00 : 100 %. The fair value of these shares of restricted stock was calculated using a Monte Carlo simulation. In scenarios where the shares do not vest, the final vested value at maturity is zero. In scenarios where vesting occurs, the final vested value on maturity is the share price on vesting date. In its calculation of the fair value of the restricted stock, the Company used an equally weighted volatility of 48.3 % for the closing price (of $ 4.37 ), a discounting based on U.S. dollar overnight indexed swap rates for the grant date, and no future dividends. The equally weighted volatility was extracted from the time series for closing prices as the standard deviation of log prices for the three years preceding the grant date. In July 2022, December 2022 and January 2023, the Company awarded 32,582 , 430,399 , and 11,806 shares of restricted stock, respectively, to employees and an executive officer which have time-based vesting conditions. In December 2022, the Company awarded 257,868 shares of restricted stock to executive officers which contained time and performance-based (market conditions related to share price performance) vesting conditions. The Company also agreed to match, on a one -for-one basis, (1) an employee’s purchase of up to $ 1.0 million worth of the Company’s shares of common stock in open market purchases, and in August 2022, the Company granted 179,498 shares of restricted stock to the employee, and (2) another employee’s purchase of up to 150,000 shares of the Company’s common stock, and in November 2022, the Company granted 150,000 shares of restricted stock to the employee. These shares of restricted stock contain time-based vesting conditions. The Company awarded 300,000 shares to an executive officer on December 31, 2022, which vested on the date of the award. The 257,868 shares of restricted stock awarded to executive officers are subject to a time-based vesting condition and a market condition and vest in full only on the date, if any, that the following conditions are satisfied: (1) a compounded annual 10 % appreciation in the Company’s stock price off a base price of $ 4.94 over the measurement period commencing on December 1, 2022 through December 1, 2025, and (2) the recipient is employed by the Company on a full-time basis when the condition in (1) is met. If either of these conditions is not satisfied, then none of the shares of restricted stock will vest and they will be forfeited. The Company’s closing price on December 1, 2022, was $ 4.08 . The appreciation levels (times and price) and vesting percentages as of each period ended are as follows: ● Prior to the first anniversary of the grant date: 0 %; ● Fiscal 2024, stock price as of December 1, 2023 is 1.1 times higher (i.e. $ 5.43 or higher) than $ 4.94 : 33 %; ● Fiscal 2025, stock price as of December 1, 2024 is 1.21 times higher (i.e. $ 5.97 or higher) than $ 4.94 : 67 %; ● Fiscal 2026, stock price as of December 1, 2025 is 1.331 times higher (i.e. $ 6.57 ) than $ 4.94 : 100 %. The fair value of these shares of restricted stock was calculated using a Monte Carlo simulation. In scenarios where the shares do not vest, the final vested value at maturity is zero. In scenarios where vesting occurs, the final vested value on maturity is the share price on vesting date. In its calculation of the fair value of the restricted stock, the Company used an equally weighted volatility of 50.1 % for the closing price (of $ 4.08 ), a discounting based on U.S. dollar overnight indexed swap rates for the grant date, and no future dividends. The equally weighted volatility was extracted from the time series for closing prices as the standard deviation of log prices for the three years preceding the grant date. 31 12. Stock-based compensation (continued) Stock option and restricted stock activity (continued) Restricted stock (continued) As fully described in Note 17 to the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the year ended June 30, 2023, the Company granted a further 12,962 and 32,405 shares to an advisor during the three and nine months ended March 31, 2023, respectively, which were ineligible for transfer until the earlier of December 31, 2022, or the occurrence of the agreed event. Vesting In July 2023, 78,800 shares of restricted stock granted to Mr. Meyer vested. In November, December 2023, February 2024 and March 2024, an aggregate of 261,003 shares of restricted stock granted to employees vested. Certain employees elected for 53,486 shares to be withheld to satisfy the withholding tax liability on the vesting of their shares. These 53,486 shares have been included in the Company’s treasury shares. In July 2022, 78,801 shares of restricted stock granted to Mr. Meyer vested and he elected for 35,460 shares to be withheld to satisfy the withholding tax liability on the vesting of these shares. In November, December 2022, February 2023 and March 2023, an aggregate of 155,358 shares of restricted stock granted to employees vested. Certain employees elected for 38,008 shares to be withheld to satisfy the withholding tax liability on the vesting of these shares. These 73,468 ( 35,460 plus 38,008 ) shares have been included in our treasury shares. Forfeitures During the three and nine months ended March 31, 2024, respectively, employees forfeited 55,539 and 77,668 shares of restricted stock following their termination of employment with the Company. During the three and nine months ended March 31, 2023, employees forfeited 18,798 shares of restricted stock following their termination of employment with the Company. Stock-based compensation charge and unrecognized compensation cost The Company recorded a stock-based compensation charge, net during the three months ended March 31, 2024 and 2023, of $ 2.1 million and $ 1.6 million, respectively, which comprised: Total charge Allocated to cost of goods sold, IT processing, servicing and support Allocated to selling, general and administration Three months ended March 31, 2024 Stock-based compensation charge $ 2,202 $ - $ 2,202 Reversal of stock compensation charge related to stock options and restricted stock forfeited ( 112 ) - ( 112 ) Total - three months ended March 31, 2024 $ 2,090 $ - $ 2,090 Three months ended March 31, 2023 Stock-based compensation charge $ 1,667 $ - $ 1,667 Reversal of stock compensation charge related to stock options and restricted stock forfeited ( 23 ) - ( 23 ) Total - three months ended March 31, 2023 $ 1,644 $ - $ 1,644 32 12. Stock-based compensation (continued) Stock-based compensation charge and unrecognized compensation cost (continued) The Company recorded a stock-based compensation charge, net during the nine months ended March 31, 2024 and 2023, of $ 5.7 million and $ 6.0 million respectively, which comprised: a Total charge Allocated to cost of goods sold, IT processing, servicing and support Allocated to selling, general and administration Nine months ended March 31, 2024 Stock-based compensation charge $ 5,782 $ - $ 5,782 Reversal of stock compensation charge related to stock options forfeited ( 129 ) - ( 129 ) Total - nine months ended March 31, 2024 $ 5,653 $ - $ 5,653 Nine months ended March 31, 2023 Stock-based compensation charge $ 5,978 $ - $ 5,978 Reversal of stock compensation charge related to stock options and restricted stock forfeited ( 23 ) - ( 23 ) Total - nine months ended March 31, 2023 $ 5,955 $ - $ 5,955 The stock-based compensation charges have been allocated to selling, general and administration based on the allocation of the cash compensation paid to the relevant employees. As of March 31, 2024, the total unrecognized compensation cost related to stock options was $ 0.6 million, which the Company expects to recognize over two years . As of March 31, 2024, the total unrecognized compensation cost related to restricted stock awards was $ 5.9 million, which the Company expects to recognize over two years . As of March 31, 2024, and June 30, 2023, respectively, the Company recorded a deferred tax asset of $ 1.1 million and $ 0.6 million, related to the stock-based compensation charge recognized related to employees of Lesaka. As of March 31, 2024, and June 30, 2023, respectively, the Company recorded a valuation allowance of $ 1.1 million and $ 0.6 million, related to the deferred tax asset because it does not believe that the stock-based compensation deduction would be utilized as it does not anticipate generating sufficient taxable income in the United States. The Company deducts the difference between the market value on the date of exercise by the option recipient and the exercise price from income subject to taxation in the United States. 13. (Loss) Earnings per share The Company has issued redeemable common stock which is redeemable at an amount other than fair value. Redemption of a class of common stock at other than fair value increases or decreases the carrying amount of the redeemable common stock and is reflected in basic earnings per share using the two-class method. There were no redemptions of common stock, or adjustments to the carrying value of the redeemable common stock during the three and nine months ended March 31, 2024 and 2023. Accordingly, the two-class method presented below does not include the impact of any redemption. The Company’s redeemable common stock is described in Note 14 to the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the year ended June 30, 2023. Basic (loss) earnings per share includes shares of restricted stock that meet the definition of a participating security because these shares are eligible to receive non -forfeitable dividend equivalents at the same rate as common stock. Basic (loss) earnings per share has been calculated using the two-class method and basic (loss) earnings per share for the three and nine months ended March 31, 2024 and 2023, reflects only undistributed earnings. The computation below of basic (loss) earnings per share excludes the net loss attributable to shares of unvested restricted stock (participating non-vested restricted stock) from the numerator and excludes the dilutive impact of these unvested shares of restricted stock from the denominator. Diluted (loss) earnings per share has been calculated to give effect to the number of shares of additional common stock that would have been outstanding if the potential dilutive instruments had been issued in each period. Stock options are included in the calculation of diluted (loss) earnings per share utilizing the treasury stock method and are not considered to be participating securities, as the stock options do not contain non-forfeitable dividend rights. The Company has excluded employee stock options to purchase 42,770 and 185,902 shares of common stock from the calculation of diluted loss per share during the nine months ended March 31, 2024 and 2023, because the effect would be antidilutive. The calculation of diluted (loss) earnings per share includes the dilutive effect of a portion of the restricted stock granted to employees as these shares of restricted stock are considered contingently returnable shares for the purposes of the diluted (loss) earnings per share calculation and the vesting conditions in respect of a portion of the restricted stock had been satisfied. 33 13. (Loss) Earnings per share (continued) The vesting conditions for all awards made are discussed in Note 17 to the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the year ended June 30, 2023. The following table presents net loss attributable to Lesaka and the share data used in the basic and diluted loss per share computations using the two-class method: Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 (in thousands except (in thousands except percent and percent and per share data) per share data) Numerator: Net loss attributable to Lesaka $ ( 4,047 ) $ ( 5,820 ) $ ( 12,405 ) $ ( 23,165 ) Undistributed loss ( 4,047 ) ( 5,820 ) ( 12,405 ) ( 23,165 ) Percent allocated to common shareholders (Calculation 1) 96 % 96 % 95 % 96 % Numerator for loss per share: basic and diluted $ ( 3,868 ) $ ( 5,605 ) $ ( 11,816 ) $ ( 22,130 ) Denominator Denominator for basic (loss) earnings per share: weighted-average common shares outstanding 60,990 61,492 60,134 60,102 Effect of dilutive securities: Denominator for diluted (loss) earnings per share: adjusted weighted average common shares outstanding and assuming conversion 60,990 61,492 60,134 60,102 Loss per share: Basic $ ( 0.06 ) $ ( 0.09 ) $ ( 0.20 ) $ ( 0.37 ) Diluted $ ( 0.06 ) $ ( 0.09 ) $ ( 0.20 ) $ ( 0.37 ) (Calculation 1) Basic weighted-average common shares outstanding (A) 60,990 61,492 60,134 60,102 Basic weighted-average common shares outstanding and unvested restricted shares expected to vest (B) 63,805 63,854 63,134 62,913 Percent allocated to common shareholders (A) / (B) 96 % 96 % 95 % 96 % Options to purchase 742,543 shares of the Company’s common stock at prices ranging from $ 3.50 to $ 11.23 per share were outstanding during the three months ended March 31, 2024, but were not included in the computation of diluted (loss) earnings per share because the options’ exercise price was greater than the average market price of the Company’s common stock. Options to purchase 293,949 shares of the Company’s common stock at prices ranging from $ 4.87 to $ 11.23 per share were outstanding during the three months ended March 31, 2023, respectively, but were not included in the computation of diluted (loss) earnings per share because the options’ exercise price was greater than the average market price of the Company’s common stock. The options, which expire at various dates through February 3, 2032, were still outstanding as of March 31, 2024. 14. Supplemental cash flow information The following table presents supplemental cash flow disclosures for the three and nine months ended March 31, 2024 and 2023: Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 Cash received from interest $ 624 $ 465 $ 1,551 $ 1,260 Cash paid for interest $ 3,464 $ 3,157 $ 12,697 $ 10,120 Cash paid for income taxes $ 88 $ 436 $ 3,498 $ 3,495 34 14. Supplemental cash flow information (continued) Disaggregation of cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash included on the Company’s unaudited condensed consolidated statement of cash flows includes restricted cash related to cash withdrawn from the Company’s debt facilities to fund ATMs. This cash may only be used to fund ATMs and is considered restricted as to use and therefore is classified as restricted cash. Cash, cash equivalents and restricted cash also includes cash in certain bank accounts that has been ceded to Nedbank. As this cash has been pledged and ceded it may not be drawn and is considered restricted as to use and therefore is classified as restricted cash as well. Refer to Note 8 for additional information regarding the Company’s facilities. The following table presents the disaggregation of cash, cash equivalents and restricted cash as of March 31, 2024 and 2023, and June 30, 2023: March 31, 2024 March 31, 2023 June 30, 2023 Cash and cash equivalents $ 55,223 $ 49,423 $ 35,499 Restricted cash 4,383 37,849 23,133 Cash, cash equivalents and restricted cash $ 59,606 $ 87,272 $ 58,632 Leases The following table presents supplemental cash flow disclosure related to leases for the three and nine months ended March 31, 2024 and 2023: Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 853 $ 695 $ 2,225 $ 2,256 Right-of-use assets obtained in exchange for lease obligations Operating leases $ 718 $ 61 $ 2,601 $ 61 15. Revenue recognition Disaggregation of revenue The following table presents the Company’s revenue disaggregated by major revenue streams, including a reconciliation to reportable segments for the three months ended March 31, 2024: Merchant Consumer Total Processing fees $ 28,682 $ 6,353 $ 35,035 South Africa 27,155 6,353 33,508 Rest of world 1,527 - 1,527 Technology products 1,795 8 1,803 South Africa 1,751 8 1,759 Rest of world 44 - 44 Telecom products and services 87,585 83 87,668 South Africa 82,484 83 82,567 Rest of world 5,101 - 5,101 Lending revenue - 6,229 6,229 Interest from customers 1,553 - 1,553 Insurance revenue - 3,178 3,178 Account holder fees - 1,560 1,560 Other 675 493 1,168 South Africa 622 493 1,115 Rest of world 53 - 53 Total revenue, derived from the following geographic locations 120,290 17,904 138,194 South Africa 113,565 17,904 131,469 Rest of world $ 6,725 $ - $ 6,725 35 15. Revenue recognition (continued) Disaggregation of revenue (continued) The following table presents the Company’s revenue disaggregated by major revenue streams, including a reconciliation to reportable segments for the three months ended March 31, 2023: Merchant Consumer Total Processing fees $ 27,541 $ 6,438 $ 33,979 South Africa 26,240 6,438 32,678 Rest of world 1,301 - 1,301 Technology products 4,322 298 4,620 South Africa 4,254 298 4,552 Rest of world 68 - 68 Telecom products and services 83,420 7 83,427 South Africa 79,308 7 79,315 Rest of world 4,112 - 4,112 Lending revenue - 5,052 5,052 Interest from customers 1,555 - 1,555 Insurance revenue - 2,584 2,584 Account holder fees - 1,419 1,419 Other 1,254 78 1,332 South Africa 1,205 78 1,283 Rest of world 49 - 49 Total revenue, derived from the following geographic locations 118,092 15,876 133,968 South Africa 112,562 15,876 128,438 Rest of world $ 5,530 $ - $ 5,530 The following table presents the Company’s revenue disaggregated by major revenue streams, including a reconciliation to reportable segments for the nine months ended March 31, 2024: Merchant Consumer Total Processing fees $ 87,246 $ 18,261 $ 105,507 South Africa 82,903 18,261 101,164 Rest of world 4,343 - 4,343 Technology products 7,035 39 7,074 South Africa 6,901 39 6,940 Rest of world 134 - 134 Telecom products and services 266,857 176 267,033 South Africa 252,000 176 252,176 Rest of world 14,857 - 14,857 Lending revenue - 17,188 17,188 Interest from customers 4,526 - 4,526 Insurance revenue - 8,686 8,686 Account holder fees - 4,430 4,430 Other 2,321 1,411 3,732 South Africa 2,169 1,411 3,580 Rest of world 152 - 152 Total revenue, derived from the following geographic locations 367,985 50,191 418,176 South Africa 348,499 50,191 398,690 Rest of world $ 19,486 $ - $ 19,486 36 15. Revenue recognition (continued) Disaggregation of revenue (continued) The following table presents the Company’s revenue disaggregated by major revenue streams, including a reconciliation to reportable segments for the nine months ended March 31, 2023: Merchant Consumer Total Processing fees $ 83,121 $ 19,696 $ 102,817 South Africa 79,175 19,696 98,871 Rest of world 3,946 - 3,946 Technology products 16,057 584 16,641 South Africa 15,871 584 16,455 Rest of world 186 - 186 Telecom products and services 241,352 13 241,365 South Africa 228,860 13 228,873 Rest of world 12,492 - 12,492 Lending revenue - 14,332 14,332 Interest from customers 4,254 - 4,254 Insurance revenue - 7,118 7,118 Account holder fees - 4,240 4,240 Other 3,724 331 4,055 South Africa 3,583 331 3,914 Rest of world 141 - 141 Total revenue, derived from the following geographic locations 348,508 46,314 394,822 South Africa 331,743 46,314 378,057 Rest of world $ 16,765 $ - $ 16,765 16. Leases The Company has entered into leasing arrangements classified as operating leases under accounting guidance. These leasing arrangements relate primarily to the lease of its corporate head office, administration offices and branch locations through which the Company operates its consumer business in South Africa. The Company’s operating leases have remaining lease terms of between one and five years . The Company also operates parts of its consumer business from locations which it leases for a period of less than one year . The Company’s operating lease expense during the three months ended March 31, 2024 and 2023 was $ 0.9 million and $ 0.7 million, respectively. The Company’s operating lease expense during the nine months ended March 31, 2024 and 2023 was $ 2.2 million and $ 2.3 million, respectively. The Company has also entered into short-term leasing arrangements, primarily for the lease of branch locations and other locations, to operate its consumer business in South Africa. The Company’s short-term lease expense during the three months ended March 31, 2024 and 2023, was $ 0.9 million and $ 1.0 million, respectively. The Company’s short-term lease expense during the nine months ended March 31, 2024 and 2023, was $ 2.8 million and $ 3.0 million, respectively. The following table presents supplemental balance sheet disclosure related to the Company’s right-of-use assets and its operating lease liabilities as of March 31, 2024 and June 30, 2023: March 31, June 30, 2024 2023 Right of use assets obtained in exchange for lease obligations: Weighted average remaining lease term (years) 3.4 1.8 Weighted average discount rate (percent) 10.1 9.7 37 16. Leases (continued) The maturities of the Company’s operating lease liabilities as of March 31, 2024, are presented below: Maturities of operating lease liabilities Year ended June 30, 2024 (excluding nine months to March 31, 2024) $ 639 2025 2,070 2026 1,543 2027 1,318 2028 1,173 Thereafter 120 Total undiscounted operating lease liabilities 6,863 Less imputed interest 1,188 Total operating lease liabilities, included in 5,675 Operating lease liability - current 1,763 Operating lease liability - long-term $ 3,912 17. Operating segments Operating segments The Company discloses segment information as reflected in the management information systems reports that its chief operating decision maker uses in making decisions and to report certain entity-wide disclosures about products and services, and the countries in which the entity holds material assets or reports material revenues. A description of the Company’s operating segments is contained in Note 21 to the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the year ended June 30, 2023. The Company analyzes its business and operations in terms of two inter-related but independent operating segments: (1) Consumer Division (“Consumer”) and (2) Merchant Division (“Merchant”). The reconciliation of the reportable segment’s revenue to revenue from external customers for the three months ended March 31, 2024 and 2023, is as follows: Revenue Reportable Segment Inter- segment From external customers Merchant $ 121,013 $ 723 $ 120,290 Consumer 17,904 - 17,904 Total for the three months ended March 31, 2024 $ 138,917 $ 723 $ 138,194 Merchant $ 118,092 $ - $ 118,092 Consumer 15,876 - 15,876 Total for the three months ended March 31, 2023 $ 133,968 $ - $ 133,968 38 17. Operating segments (continued) Operating segments (continued) The reconciliation of the reportable segment’s revenue to revenue from external customers for the nine months ended March 31, 2024 and 2023, is as follows: Revenue Reportable Segment Inter- segment From external customers Merchant $ 370,244 $ 2,259 $ 367,985 Consumer 50,191 - 50,191 Total for the nine months ended March 31, 2024 $ 420,435 $ 2,259 $ 418,176 Merchant $ 348,508 $ - $ 348,508 Consumer 46,314 - 46,314 Total for the nine months ended March 31, 2023 $ 394,822 $ - $ 394,822 The Company evaluates segment performance based on segment earnings before interest, tax, depreciation and amortization (“EBITDA”), adjusted for items mentioned in the next sentence (“Segment Adjusted EBITDA”), the Company’s reportable segments’ measure of profit or loss. The Company does not allocate once-off items, stock-based compensation charges, certain lease expenses (“Lease adjustments”), depreciation and amortization, impairment of goodwill or other intangible assets, other items (including gains or losses on disposal of investments, fair value adjustments to equity securities), interest income, interest expense, income tax expense or (earnings) loss from equity-accounted investments to its reportable segments. Group costs generally include: employee related costs in relation to employees specifically hired for group roles and related directly to managing the US-listed entity; expenditures related to compliance with the Sarbanes-Oxley Act of 2002; non-employee directors’ fees; legal fees; group and US-listed related audit fees; and directors and officer’s insurance premiums. Once-off items represents non-recurring expense items, including costs related to acquisitions and transactions consummated or ultimately not pursued. Unrealized loss FV for currency adjustments represents foreign currency mark-to-market adjustments on certain intercompany accounts. The Lease adjustments reflect lease expenses and the Stock- based compensation adjustments reflect stock-based compensation expense and are both excluded from the calculation of Segment Adjusted EBITDA and are therefore reported as reconciling items to reconcile the reportable segments’ Segment Adjusted EBITDA to the Company’s loss before income tax expense. The reconciliation of the reportable segments’ measure of profit or loss to loss before income taxes for the three and nine months ended March 31, 2024 and 2023, is as follows: Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 Reportable segments' measure of profit or loss $ 12,752 $ 9,939 $ 34,934 $ 26,136 Operating loss: Group costs ( 2,199 ) ( 2,293 ) ( 6,032 ) ( 6,849 ) Once-off costs ( 907 ) ( 1,141 ) ( 169 ) ( 1,858 ) Unrealized Loss FV for currency adjustments ( 121 ) ( 43 ) ( 101 ) ( 43 ) Lease adjustments ( 850 ) ( 696 ) ( 2,224 ) ( 2,255 ) Stock-based compensation charge adjustments ( 2,090 ) ( 1,644 ) ( 5,653 ) ( 5,955 ) Depreciation and amortization ( 5,791 ) ( 5,975 ) ( 17,460 ) ( 17,892 ) Reversal of allowance of EMI doubtful debt - - 250 - Gain on disposal of equity-accounted investments - ( 329 ) - ( 193 ) Interest income 628 469 1,562 1,269 Interest expense ( 4,581 ) ( 4,984 ) ( 14,312 ) ( 13,408 ) Loss before income tax expense $ ( 3,159 ) $ ( 6,697 ) $ ( 9,205 ) $ ( 21,048 ) 39 17. Operating segments (continued) Operating segments (continued) The following tables summarize supplemental segment information for the three and nine months ended March 31, 2024 and 2023: Three months ended Nine months ended March 31, March 31, 2024 2023 2024 2023 Revenues Merchant $ 121,013 $ 118,092 $ 370,244 $ 348,508 Consumer 17,904 15,876 50,191 46,314 Total reportable segment revenue 138,917 133,968 420,435 394,822 Segment Adjusted EBITDA Merchant (1) 8,394 8,290 25,148 25,303 Consumer (1) 4,358 1,649 9,786 833 Total Segment Adjusted EBITDA 12,752 9,939 34,934 26,136 Depreciation and amortization Merchant 2,050 1,898 6,169 5,522 Consumer 179 288 527 811 Subtotal: Operating segments 2,229 2,186 6,696 6,333 Group costs 3,562 3,789 10,764 11,559 Total 5,791 5,975 17,460 17,892 Expenditures for long-lived assets Merchant 2,797 3,020 7,638 10,545 Consumer 146 1,697 312 2,665 Subtotal: Operating segments 2,943 4,717 7,950 13,210 Group costs - - - - Total $ 2,943 $ 4,717 $ 7,950 $ 13,210 (1) Segment Adjusted EBITDA for Consumer includes retrenchment costs of $ 0.01 million (ZAR 0.1 million) for the three months ended March 31, 2024. Segment Adjusted EBITDA for Merchant includes retrenchment costs of $ 0.2 million (ZAR 4.7 million) and Consumer includes retrenchment costs of $ 0.2 million (ZAR 2.9 million) for the nine months ended March 31, 2024. The segment information as reviewed by the chief operating decision maker does not include a measure of segment assets per segment as all of the significant assets are used in the operations of all, rather than any one, of the segments. The Company does not have dedicated assets assigned to a particular operating segment. Accordingly, it is not meaningful to attempt an arbitrary allocation and segment asset allocation is therefore not presented. 18. Income tax Income tax in interim periods For the purposes of interim financial reporting, the Company determines the appropriate income tax provision by first applying the effective tax rate expected to be applicable for the full fiscal year to ordinary income. This amount is then adjusted for the tax effect of significant unusual items, for instance, changes in tax law, valuation allowances and non-deductible transaction-related expenses that are reported separately, and have an impact on the tax charge. The cumulative effect of any change in the enacted tax rate, if and when applicable, on the opening balance of deferred tax assets and liabilities is also included in the tax charge as a discrete event in the interim period in which the enactment date occurs. For the three and nine months ended March 31, 2024, the Company’s effective tax rate was impacted by the tax expense recorded by the Company’s profitable South African operations, non-deductible expenses, the on-going losses incurred by certain of the Company’s South African businesses and the associated valuation allowances created related to the deferred tax assets recognized regarding net operating losses incurred by these entities. For the three and nine months ended March 31, 2023, the Company’s effective tax rate was impacted by a reduction in the enacted South African corporate income tax rate from 28 % to 27 % from January 2023 (but backdated to July 1, 2022), the tax expense recorded by the Company’s profitable South African operations, non-deductible expenses, the on-going losses incurred by certain of the Company’s South African businesses and the associated valuation allowances created related to the deferred tax assets recognized regarding net operating losses incurred by these entities. 40 18. Income tax (continued) Uncertain tax positions The Company had no significant uncertain tax positions during the three months ended March 31, 2024, and therefore, the Company had no accrued interest related to uncertain tax positions on its balance sheet. The Company does no t expect changes related to its unrecognized tax benefits will have a significant impact on its results of operations or financial position in the next 12 months. The Company has no unrecognized tax benefits. The Company files income tax returns mainly in South Africa, Botswana and in the U.S. federal jurisdiction. As of March 31, 2024, the Company’s South African subsidiaries are no longer subject to income tax examination by the South African Revenue Service for periods before June 30, 2019. The Company is subject to income tax in other jurisdictions outside South Africa, none of which are individually material to its financial position, statement of cash flows, or results of operations. 19. Commitments and contingencies Guarantees The South African Revenue Service and certain of the Company’s customers, suppliers and other business partners have asked the Company to provide them with guarantees, including standby letters of credit, issued by South African banks. The Company is required to procure these guarantees for these third parties to operate its business. RMB has issued guarantees to these third parties amounting to ZAR 33.1 million ($ 1.8 million, translated at exchange rates applicable as of March 31, 2024) thereby utilizing part of the Company’s short-term facilities. The Company pays commission of between 3.42 % per annum to 3.44 % per annum of the face value of these guarantees and does not recover any of the commission from third parties. Nedbank has issued guarantees to these third parties amounting to ZAR 2.1 million ($ 0.1 million, translated at exchange rates applicable as of March 31, 2024) thereby utilizing part of the Company’s short-term facilities. The Company pays commission of between 0.47 % per annum to 1.84 % per annum of the face value of these guarantees and does not recover any of the commission from third parties. The Company has not recognized any obligation related to these guarantees in its consolidated balance sheet as of March 31, 2024. The maximum potential amount that the Company could pay under these guarantees is ZAR 35.2 million ($ 1.9 million, translated at exchange rates applicable as of March 31, 2024). As discussed in Note 8, the Company has ceded and pledged certain bank accounts to Nedbank as security for the guarantees issued by them with an aggregate value of ZAR 2.1 million ($ 0.1 million, translated at exchange rates applicable as of March 31, 2024). The guarantees have reduced the amount available under its indirect and derivative facilities in the Company’s short-term credit facilities described in Note 8. Contingencies The Company is subject to a variety of insignificant claims and suits that arise from time to time in the ordinary course of business. Management currently believes that the resolution of these other matters, individually or in the aggregate, will not have a material adverse impact on the Company’s financial position, results of operations or cash flows. 20. Subsequent events April 2024 acquisition of Touchsides In February 2024, the Company announced that it had entered into a Sale and Purchase Agreement with Heineken International B.V. to acquire all of the outstanding equity of Touchsides (Pty) Ltd (“Touchsides”). The transaction was subject to customary closing conditions and the final conditions were satisfied in April 2024. The transaction closed on April 30, 2024. The total purchase consideration was ZAR 42.4 million ($ 2.3 million, translated at exchange rates applicable as of April 30, 2024). The Company has commenced the purchase price allocation related to this transaction however the process had not been completed as of the date of filing this Quarterly Report on Form 10-Q on May 8, 2024. The Company expects to include its preliminary allocation of the purchase consideration related to this acquisition in its audited financial statements to be included in its Annual Report on Form 10-K for the year ended June 30, 2024. The Company incurred transaction related expenditures of $ 0.1 million (ZAR 1.9 million) during the nine months to March 31, 2024, related to the acquisition of Touchsides. These transaction related expenditures are included in the caption selling, general and administration in the Company’s unaudited condensed consolidated statements of operations. The Company does not expect to incur any significant expenditure related to the transaction during the three months ended June 30, 2024. 41 20. Subsequent events (continued) April 2024 acquisition of Touchsides (continued) Touchsides is a leading data analytics and insights company, and highly complementary with the Company’s Kazang business. The acquisition significantly expands Kazang’s footprint in the informal market by adding an established solution that has a strong presence in the licensed tavern market. Touchsides has an installed base of over 10,000 active POS terminals across South Africa’s licensed taverns, and processes more than 1.5 million transactions per day. The business provides platform-as-a-service (“PaaS”) and software-as-a-service (“SaaS”) solutions to licensed tavern outlets, enabling the measurement of sales activity in real-time, management of stock levels and informing commercial decisions, such as pricing and promotional offers. The data and insights gathered from these terminals carries significant value and potential to be monetized through relationships with a range of clients including fast-moving consumer goods companies, retailers, wholesalers, route-to-market suppliers, and financiers. Touchsides has been allocated to our Merchant operating segment. May 2024 offer to acquire Adumo On May 7, 2024, the Company entered into a Sale and Purchase Agreement (the “Sale Agreement”) with Lesaka SA”), and the Sellers (as defined in the Sale Agreement). Pursuant to the Sale Agreement and subject to its terms and conditions, Lesaka, through its subsidiary, Lesaka SA, agreed to acquire, and the Sellers agreed to sell, all of the outstanding equity interests and certain claims in the Adumo (RF) Proprietary Limited (“Adumo”). The purchase consideration will be settled through the combination of an issuance of 17,279,803 shares of the Company’s common stock and a ZAR 232 million ($ 12.5 million, translated at the prevailing rate of $1: ZAR 18.5 as of May 7, 2024) payment in cash. The share issuance was based off of the Base Purchase Consideration, as defined in the Sale Agreement, of ZAR 1.59 billion ($ 85.9 million), less the ZAR 232 million cash payment, implying a value per share of $ 4.25 ((ZAR 1.59 billion – ZAR 0.232 billion)/ 17,279,803 / ZAR 18.5). The Sale Agreement includes customary covenants from the Sellers, including (i) to conduct the business in the ordinary course during the period between the execution of the Sale Agreement and the closing of the transactions contemplated thereby, and (ii) not to engage in certain kinds of transactions during such period. The closing of the transaction is subject to customary closing conditions, including (i) approval from the competition authorities of South Africa and Namibia; (ii) exchange control approval from the financial surveillance department of the South African Reserve Bank; (iii) the Company obtaining confirmation from RMB that it has sufficient funds to settle the cash portion of the purchase consideration; (iv) approval of Adumo shareholders (including preference shareholders) with respect to entering into and implementation of the Sale Agreement, and all other agreements and transactions contemplated in the Sale Agreement by June 6, 2024; (v) obtaining the consent of Adumo’s lender regarding Adumo entering into and implementing the Sale Agreement, and all other agreements and transactions contemplated in the Sale Agreement by June 5, 2024, (vi) the release of certain Seller’s shares held as security by such bank; (vi) obtaining the consent of the lender of one of Adumo’s shareholders regarding Adumo entering into the transaction by June 6, 2024; (vii) the Company obtaining all necessary regulatory and shareholder approval to issue the Consideration Shares to the Sellers; (viii) on or before June 6, 2024, the Company signing a written addendum to the Policy Agreement with International Finance Corporation that provides for the inclusion of the Consideration Shares attributable to certain Seller shareholders in the definition of “Put Shares” under the Policy Agreement, and related changes; and (ix) obtaining certain third-party consents. In addition, the closing of the transaction is subject to either: (i) on or before July 6, 2024, the direct and/or indirect shareholders of one of the Sellers providing written unconditional undertakings to purchase all of certain of its shareholders pro rata entitlements to the Consideration Shares in consideration for an aggregate amount equal to ZAR 285,772,238 ($ 14.0 million) (the “Replacement Cash Component”); or (ii) if the foregoing does not occur in a timely manner then, on or before October 31, 2024, Lesaka SA (or is nominee) will enter into a written unconditional agreement with Crossfin SPV in relation to the acquisition of all of such entitlements in respect of all such Consideration Shares (other than those which are required to be liquidated in order to satisfy cash tax obligations), provided that the aggregate consideration for such entitlements will be equal to the Replacement Cash Component and provided further that (i) Lesaka SA (or its nominee) has provided a bank guarantee from RMB or other South African registered bank in respect of the settlement of such aggregate consideration and (ii) that, to the extent applicable, Lesaka SA’s nominee has, prior to the conclusion thereof, obtained all approvals as may be required to conclude and implement such agreement. 42 20. Subsequent events (continued) May 2024 offer to acquire Adumo (continued) The Company has agreed to file a resale registration statement with the United States Securities and Exchange Commission (“SEC”) covering the resale of the Consideration Shares by the Sellers following the closing of the transaction. The Company has undertaken to use its commercially reasonable efforts to have the resale registration statement declared effective by the SEC following its filing. The Company incurred transaction-related expenditures of $ 0.6 million and $ 0.7 million during the three and nine months ended March 31, 2024, related to the process to acquire Adumo. The Company expects to incur a further $ 2.2 million in transaction costs over the remainder of the 2024 calendar year. 43